Followers | 645 |
Posts | 10,613 |
Boards Moderated | 2 |
Alias Born | 03/07/2015 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
MSRM
Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast.
Estero, FL, July 19, 2023 – Mushrooms Inc. (OTC: MSRM) (the “Company” or “MSRM) is pleased to announce that its CEO, Kimberly Carlson, recently appeared on the esteemed Psychedelic Spotlight Podcast to discuss the exciting potential of the industrial mushroom industry. As the first company trading on the US stock market focused on the industrial side of mushrooms, Mushrooms Inc. is leading the way in revolutionizing this emerging sector.
To watch or listen to the complete interview featuring Kimberly Carlson on Psychedelic Spotlight, please visit the following link: https://psychedelicspotlight.com/using-mycelium-for-a-sustainable-future-feat-kimberly-carlson/
During the podcast episode hosted by David Flores (CEO of Psychedelic Spotlight), Kimberly Carlson shared insights into the vision and mission of Mushrooms Inc. The Company is dedicated to supporting the growth of the mushroom industry through collaboration, innovation, and development. At the heart of Mushrooms Inc. lies a commitment to creating and supporting environmentally beneficial product innovation.
With a specific focus on the industrial application of mycelium, Mushrooms Inc. aims to develop carbon-neutral products for the building, textile, and healthcare industries. By harnessing the power of mycology, Mushrooms Inc. seeks to advance the creation of scientifically proven products that promote the health of the body, mind, and environment which includes remediation of toxic substances using mycelium also known as Myco-remediation.
Along with providing Mr. Flores with an overview of Mushrooms Inc., Ms. Carlson also shared insight into her own personal passion for working within the mushroom sector and why she believes mycelium holds the potential to promote a healthier and more sustainable environment for all of society.
"The potential of the industrial mushroom sector is immense, and Mushrooms Inc. is at the forefront of driving innovation in this field," said Kimberly Carlson, CEO of Mushrooms Inc. "Through our research and development efforts, we are committed to delivering sustainable solutions that benefit not only our customers but also the planet.
I am grateful for the opportunity to have had Mushrooms Inc. featured on the Psychedelic Spotlight Podcast, and more specifically, for the opportunity to provide their audience, as well as many others following the public markets, with an initial introduction into some the exiting things we have planned for MSRM.
In the weeks and months ahead, I look forward to being able to share some of the progress we anticipate making as we strive to truly position MSRM as an industrial mushroom leader.”
Mushrooms Inc. recognizes that true innovation comes from collaboration and learning from pioneers in the field. By fostering working relationships and engaging with experts in mycology, the Company is paving the way for groundbreaking advancements in the industry.
Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release | 02/23/2023
ESTERO, FL / ACCESSWIRE / February 23, 2023 / Mushrooms, Inc. (OTC PINK:MSRM) (the "Company") has been quietly making progress within this exciting multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology.
Mushrooms Inc. is developing profitable pathways to sustain the research and development branch which is necessary to achieve viable industrial innovation in this new field.
MSRM is targeting grants specific to their goals, working with pioneers, scientists, and universities, on a global scale to develop scientifically proven products that advance health of body, mind, and environment. They have multiple proposals that they are currently reviewing for their costs to bring to market, timelines, scalability, as well as their positive financial, environmental and health impact. These proposals include a patentable process for the development of mycelium-based building supplies, a patentable process for mushroom related cosmetic and anti-aging skin products, a superfood product not currently seen in the marketplace as well as several remediation projects with new product innovation as an end result. These proposals are being assessed while keeping the progress on an off-shore lab and scientists for an evolved patentable mycelium thread.
GROWTH STRATEGY
In order to offset research costs and time on the industrial development side we are establishing pillars of development outside of the industrial mushroom market through acquisitions and joint ventures. The business model is based on the amazing qualities of mycelium and its networking capabilities as well as its ability to benefit from the network its developing.
CEO Kimberly Carlson shared, "I have been fortunate to connect with amazing pioneers and innovators in differing areas of the Mushroom Market in the US and abroad. Three realities have been consistent with the people behind the businesses and their processes. One is that this business model can bring like-minded companies together in order to benefit and fruit from a shared network under the public umbrella. Secondly, there are natural and substantial cross-points between these companies to mutually benefit from each other while growing as a whole. And the third is that there is a desire for many of these businesses to unite their expertise to others and share from a unified gain. By combining the power of shared ideals and resources through joint ventures, we can move as larger more developed companies do, but without limiting quality and compassion for social and environmental governance."
With a focus on profitability and mutually beneficial cross points, MSRM is assessing partnerships with complimentary businesses which would strategically advance the Company's reach into related markets through joint ventures and M&A activity.
Establishing pillars of development outside of the industrial mushroom market allows for a broad scope of proven profitability and cross-sharing of resources.
We seek to enter partnerships in the Cultivation Market, which includes substrate, spawn production, and fruiting. Cultivation gives life to all market pillars to some degree. It feeds directly into the Mushroom Nutraceutical and Medicinal Psylocibin Market with the addition of extraction, quality testing, product development, and processing. The Medicinal Mushroom Market requires legalization and branches into wellness retreats, treatment certifications and clinics.
MSRM is also evaluating several companies involved in the Myco-Remediation Market which uses fungi to clean oil spills, heavy metals, plastics and other pollutants from soil, water, and the atmosphere. All of these markets relate to the industrial and health innovation that the Company is pursuing in differing aspects and creates a connecting point for acceleration, mutual benefit and market share.
It is the belief of MSRM that connecting these pillars of the mushroom market through joint ventures and acquisitions, while focusing their innovation efforts on the industrial side of the market, will garner cross benefits financially and accelerate timelines during the major research and development phases.
We are simultaneously creating a vertically integrated business model for the businesses involved by aligning strengths between the companies under the umbrella of MSRM.
From an investor perspective, we are creating an avenue for investors to support a larger portion of the mushroom market, establishing a broader financial base of support for and from the networked companies while allowing for a more elastic ability to pivot, expand and connect to new industry pathways as they surface.
Market Opportunity
Mushrooms, Inc. operates in the North American segment of the functional mushroom market in the mycelium material and mushroom supplement product types. According to various industrial research firms, the global functional mushroom market is projected to show a compounded annual growth rate of over 9% for the next five years (Industry Arc and Vantage Market Research). The North American edible mushroom market was worth 11.99 billion in 2023 and is growing at a compounded annual growth rate of 9.48%, forecast to reach 20.91 billion by 2028 (Market Data Forecast). The North American functional mushroom market held 33.8% of the global market in 2020 and is growing at a compounded annual growth rate of 7% (Industry Arc).
Overview
Mushrooms, Inc. is a developing-stage emerging consumer products platform focused on the manufacturing and marketing of highly differentiated mushroom-based materials and functional supplements. The core growth pillars of the Mushrooms, Inc. platform are currently based on developing functional mushroom technologies. As a result of growing consumer demand for innovative, sustainable, and carbon-neutral products, Mushrooms, Inc. plans to grow revenues by penetrating the multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology, as well as expanding our platform to include the creation of supplements based on the proven health benefits of mushrooms.
Mushrooms, Inc. seeks to drive the growth of the bourgeoning functional mushroom industry through product innovation and development. Our current core business activity is environmentally beneficial product innovation utilizing self-growing, fibrous, and natural composite materials with controlled physical properties that can be produced in large quantities. Our product technologies focus on mycelium, the main component of fungi. This emerging biotechnology is used in the creation of carbon neutral products for the building, textile, packaging, and health care industries, as well as in the creation of supplements based on the proven health benefits of mushrooms.
Currently, our research focuses primarily on the significant thermal stability of mycelium materials, a result of mycelium's unique degradation qualities that expand the potential fields of application for mushroom-based products. Mushrooms, Inc.'s long-term goal is to build a strong scalable and widely recognized brand that authentically focuses on sustainable mushroom ingredients and novel functionality stemming from innovative biotech and materials science.
For more information, email info@mushroomsinc.com or visit www.mushroomsinc.com
07/19/2023 Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast Press Release
02/23/2023 Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release
04/20/2023 Quarterly Report for the period ended March 31, 2023
03/06/2023 Attorney Letter with Respect to Current Information - Shell Status Opinion MSRM
03/06/2023 Attorney Letter with Respect to Current Information - MSRM - Current Information Letter
03/06/2023 Annual Report - MSRM 2022 Annual Report
11/29/2022 Mushrooms, Inc. Announces Name and Ticker Symbol Change on OTC Markets to “MSRM” Press Release
https://www.otcmarkets.com/stock/MSRM/disclosure
08/23/2022 Marijuana Strategic Ventures, Inc. (OTC: MSVI) Now Mushrooms Inc., Announces Filing of Provisional Patent for Novel Mycelium Thread Press Release
Outstanding Shares 38,485,760 07/18/2023
Restricted 32,527,735 07/18/2023
Unrestricted 5,958,025 07/18/2023
Authorized Shares 400,000,000 07/18/2023
update by CEO:
see twitter https://twitter.com/MushroomsInc
MSRM This is totally under the Radar and is REAL. Check the SS , they did file a Patent that is coming up , they do have the product and their Mgt Team actually knows what they are doing.
https://otcmarkets.com/stock/MSRM/security
https://mushroomsinc.com/team-3
https://twitter.com/MushroomsInc
MSRM Unrestricted Shares 5,958,025 07/18/2023
Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast.
Estero, FL, July 19, 2023 – Mushrooms Inc. (OTC: MSRM) (the “Company” or “MSRM) is pleased to announce that its CEO, Kimberly Carlson, recently appeared on the esteemed Psychedelic Spotlight Podcast to discuss the exciting potential of the industrial mushroom industry. As the first company trading on the US stock market focused on the industrial side of mushrooms, Mushrooms Inc. is leading the way in revolutionizing this emerging sector.
To watch or listen to the complete interview featuring Kimberly Carlson on Psychedelic Spotlight, please visit the following link: https://psychedelicspotlight.com/using-mycelium-for-a-sustainable-future-feat-kimberly-carlson/
During the podcast episode hosted by David Flores (CEO of Psychedelic Spotlight), Kimberly Carlson shared insights into the vision and mission of Mushrooms Inc. The Company is dedicated to supporting the growth of the mushroom industry through collaboration, innovation, and development. At the heart of Mushrooms Inc. lies a commitment to creating and supporting environmentally beneficial product innovation.
With a specific focus on the industrial application of mycelium, Mushrooms Inc. aims to develop carbon-neutral products for the building, textile, and healthcare industries. By harnessing the power of mycology, Mushrooms Inc. seeks to advance the creation of scientifically proven products that promote the health of the body, mind, and environment which includes remediation of toxic substances using mycelium also known as Myco-remediation.
Along with providing Mr. Flores with an overview of Mushrooms Inc., Ms. Carlson also shared insight into her own personal passion for working within the mushroom sector and why she believes mycelium holds the potential to promote a healthier and more sustainable environment for all of society.
"The potential of the industrial mushroom sector is immense, and Mushrooms Inc. is at the forefront of driving innovation in this field," said Kimberly Carlson, CEO of Mushrooms Inc. "Through our research and development efforts, we are committed to delivering sustainable solutions that benefit not only our customers but also the planet.
I am grateful for the opportunity to have had Mushrooms Inc. featured on the Psychedelic Spotlight Podcast, and more specifically, for the opportunity to provide their audience, as well as many others following the public markets, with an initial introduction into some the exiting things we have planned for MSRM.
In the weeks and months ahead, I look forward to being able to share some of the progress we anticipate making as we strive to truly position MSRM as an industrial mushroom leader.”
Mushrooms Inc. recognizes that true innovation comes from collaboration and learning from pioneers in the field. By fostering working relationships and engaging with experts in mycology, the Company is paving the way for groundbreaking advancements in the industry.
Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release | 02/23/2023
ESTERO, FL / ACCESSWIRE / February 23, 2023 / Mushrooms, Inc. (OTC PINK:MSRM) (the "Company") has been quietly making progress within this exciting multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology.
Mushrooms Inc. is developing profitable pathways to sustain the research and development branch which is necessary to achieve viable industrial innovation in this new field.
MSRM is targeting grants specific to their goals, working with pioneers, scientists, and universities, on a global scale to develop scientifically proven products that advance health of body, mind, and environment. They have multiple proposals that they are currently reviewing for their costs to bring to market, timelines, scalability, as well as their positive financial, environmental and health impact. These proposals include a patentable process for the development of mycelium-based building supplies, a patentable process for mushroom related cosmetic and anti-aging skin products, a superfood product not currently seen in the marketplace as well as several remediation projects with new product innovation as an end result. These proposals are being assessed while keeping the progress on an off-shore lab and scientists for an evolved patentable mycelium thread.
GROWTH STRATEGY
In order to offset research costs and time on the industrial development side we are establishing pillars of development outside of the industrial mushroom market through acquisitions and joint ventures. The business model is based on the amazing qualities of mycelium and its networking capabilities as well as its ability to benefit from the network its developing.
CEO Kimberly Carlson shared, "I have been fortunate to connect with amazing pioneers and innovators in differing areas of the Mushroom Market in the US and abroad. Three realities have been consistent with the people behind the businesses and their processes. One is that this business model can bring like-minded companies together in order to benefit and fruit from a shared network under the public umbrella. Secondly, there are natural and substantial cross-points between these companies to mutually benefit from each other while growing as a whole. And the third is that there is a desire for many of these businesses to unite their expertise to others and share from a unified gain. By combining the power of shared ideals and resources through joint ventures, we can move as larger more developed companies do, but without limiting quality and compassion for social and environmental governance."
With a focus on profitability and mutually beneficial cross points, MSRM is assessing partnerships with complimentary businesses which would strategically advance the Company's reach into related markets through joint ventures and M&A activity.
Establishing pillars of development outside of the industrial mushroom market allows for a broad scope of proven profitability and cross-sharing of resources.
We seek to enter partnerships in the Cultivation Market, which includes substrate, spawn production, and fruiting. Cultivation gives life to all market pillars to some degree. It feeds directly into the Mushroom Nutraceutical and Medicinal Psylocibin Market with the addition of extraction, quality testing, product development, and processing. The Medicinal Mushroom Market requires legalization and branches into wellness retreats, treatment certifications and clinics.
MSRM is also evaluating several companies involved in the Myco-Remediation Market which uses fungi to clean oil spills, heavy metals, plastics and other pollutants from soil, water, and the atmosphere. All of these markets relate to the industrial and health innovation that the Company is pursuing in differing aspects and creates a connecting point for acceleration, mutual benefit and market share.
It is the belief of MSRM that connecting these pillars of the mushroom market through joint ventures and acquisitions, while focusing their innovation efforts on the industrial side of the market, will garner cross benefits financially and accelerate timelines during the major research and development phases.
We are simultaneously creating a vertically integrated business model for the businesses involved by aligning strengths between the companies under the umbrella of MSRM.
From an investor perspective, we are creating an avenue for investors to support a larger portion of the mushroom market, establishing a broader financial base of support for and from the networked companies while allowing for a more elastic ability to pivot, expand and connect to new industry pathways as they surface.
Market Opportunity
Mushrooms, Inc. operates in the North American segment of the functional mushroom market in the mycelium material and mushroom supplement product types. According to various industrial research firms, the global functional mushroom market is projected to show a compounded annual growth rate of over 9% for the next five years (Industry Arc and Vantage Market Research). The North American edible mushroom market was worth 11.99 billion in 2023 and is growing at a compounded annual growth rate of 9.48%, forecast to reach 20.91 billion by 2028 (Market Data Forecast). The North American functional mushroom market held 33.8% of the global market in 2020 and is growing at a compounded annual growth rate of 7% (Industry Arc).
Overview
Mushrooms, Inc. is a developing-stage emerging consumer products platform focused on the manufacturing and marketing of highly differentiated mushroom-based materials and functional supplements. The core growth pillars of the Mushrooms, Inc. platform are currently based on developing functional mushroom technologies. As a result of growing consumer demand for innovative, sustainable, and carbon-neutral products, Mushrooms, Inc. plans to grow revenues by penetrating the multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology, as well as expanding our platform to include the creation of supplements based on the proven health benefits of mushrooms.
Mushrooms, Inc. seeks to drive the growth of the bourgeoning functional mushroom industry through product innovation and development. Our current core business activity is environmentally beneficial product innovation utilizing self-growing, fibrous, and natural composite materials with controlled physical properties that can be produced in large quantities. Our product technologies focus on mycelium, the main component of fungi. This emerging biotechnology is used in the creation of carbon neutral products for the building, textile, packaging, and health care industries, as well as in the creation of supplements based on the proven health benefits of mushrooms.
Currently, our research focuses primarily on the significant thermal stability of mycelium materials, a result of mycelium's unique degradation qualities that expand the potential fields of application for mushroom-based products. Mushrooms, Inc.'s long-term goal is to build a strong scalable and widely recognized brand that authentically focuses on sustainable mushroom ingredients and novel functionality stemming from innovative biotech and materials science.
For more information, email info@mushroomsinc.com or visit www.mushroomsinc.com
07/19/2023 Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast Press Release
02/23/2023 Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release
04/20/2023 Quarterly Report for the period ended March 31, 2023
03/06/2023 Attorney Letter with Respect to Current Information - Shell Status Opinion MSRM
03/06/2023 Attorney Letter with Respect to Current Information - MSRM - Current Information Letter
03/06/2023 Annual Report - MSRM 2022 Annual Report
11/29/2022 Mushrooms, Inc. Announces Name and Ticker Symbol Change on OTC Markets to “MSRM” Press Release
https://www.otcmarkets.com/stock/MSRM/disclosure
08/23/2022 Marijuana Strategic Ventures, Inc. (OTC: MSVI) Now Mushrooms Inc., Announces Filing of Provisional Patent for Novel Mycelium Thread Press Release
Outstanding Shares 38,485,760 07/18/2023
Restricted 32,527,735 07/18/2023
Unrestricted 5,958,025 07/18/2023
Authorized Shares 400,000,000 07/18/2023
update by CEO:
see twitter https://twitter.com/MushroomsInc
MSRM This is totally under the Radar and is REAL. Check the SS , they did file a Patent that is coming up , they do have the product and their Mgt Team actually knows what they are doing.
https://otcmarkets.com/stock/MSRM/security
https://mushroomsinc.com/team-3
https://twitter.com/MushroomsInc
MSRM Unrestricted Shares 5,958,025 07/18/2023
Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast.
Estero, FL, July 19, 2023 – Mushrooms Inc. (OTC: MSRM) (the “Company” or “MSRM) is pleased to announce that its CEO, Kimberly Carlson, recently appeared on the esteemed Psychedelic Spotlight Podcast to discuss the exciting potential of the industrial mushroom industry. As the first company trading on the US stock market focused on the industrial side of mushrooms, Mushrooms Inc. is leading the way in revolutionizing this emerging sector.
To watch or listen to the complete interview featuring Kimberly Carlson on Psychedelic Spotlight, please visit the following link: https://psychedelicspotlight.com/using-mycelium-for-a-sustainable-future-feat-kimberly-carlson/
During the podcast episode hosted by David Flores (CEO of Psychedelic Spotlight), Kimberly Carlson shared insights into the vision and mission of Mushrooms Inc. The Company is dedicated to supporting the growth of the mushroom industry through collaboration, innovation, and development. At the heart of Mushrooms Inc. lies a commitment to creating and supporting environmentally beneficial product innovation.
With a specific focus on the industrial application of mycelium, Mushrooms Inc. aims to develop carbon-neutral products for the building, textile, and healthcare industries. By harnessing the power of mycology, Mushrooms Inc. seeks to advance the creation of scientifically proven products that promote the health of the body, mind, and environment which includes remediation of toxic substances using mycelium also known as Myco-remediation.
Along with providing Mr. Flores with an overview of Mushrooms Inc., Ms. Carlson also shared insight into her own personal passion for working within the mushroom sector and why she believes mycelium holds the potential to promote a healthier and more sustainable environment for all of society.
"The potential of the industrial mushroom sector is immense, and Mushrooms Inc. is at the forefront of driving innovation in this field," said Kimberly Carlson, CEO of Mushrooms Inc. "Through our research and development efforts, we are committed to delivering sustainable solutions that benefit not only our customers but also the planet.
I am grateful for the opportunity to have had Mushrooms Inc. featured on the Psychedelic Spotlight Podcast, and more specifically, for the opportunity to provide their audience, as well as many others following the public markets, with an initial introduction into some the exiting things we have planned for MSRM.
In the weeks and months ahead, I look forward to being able to share some of the progress we anticipate making as we strive to truly position MSRM as an industrial mushroom leader.”
Mushrooms Inc. recognizes that true innovation comes from collaboration and learning from pioneers in the field. By fostering working relationships and engaging with experts in mycology, the Company is paving the way for groundbreaking advancements in the industry.
Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release | 02/23/2023
ESTERO, FL / ACCESSWIRE / February 23, 2023 / Mushrooms, Inc. (OTC PINK:MSRM) (the "Company") has been quietly making progress within this exciting multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology.
Mushrooms Inc. is developing profitable pathways to sustain the research and development branch which is necessary to achieve viable industrial innovation in this new field.
MSRM is targeting grants specific to their goals, working with pioneers, scientists, and universities, on a global scale to develop scientifically proven products that advance health of body, mind, and environment. They have multiple proposals that they are currently reviewing for their costs to bring to market, timelines, scalability, as well as their positive financial, environmental and health impact. These proposals include a patentable process for the development of mycelium-based building supplies, a patentable process for mushroom related cosmetic and anti-aging skin products, a superfood product not currently seen in the marketplace as well as several remediation projects with new product innovation as an end result. These proposals are being assessed while keeping the progress on an off-shore lab and scientists for an evolved patentable mycelium thread.
GROWTH STRATEGY
In order to offset research costs and time on the industrial development side we are establishing pillars of development outside of the industrial mushroom market through acquisitions and joint ventures. The business model is based on the amazing qualities of mycelium and its networking capabilities as well as its ability to benefit from the network its developing.
CEO Kimberly Carlson shared, "I have been fortunate to connect with amazing pioneers and innovators in differing areas of the Mushroom Market in the US and abroad. Three realities have been consistent with the people behind the businesses and their processes. One is that this business model can bring like-minded companies together in order to benefit and fruit from a shared network under the public umbrella. Secondly, there are natural and substantial cross-points between these companies to mutually benefit from each other while growing as a whole. And the third is that there is a desire for many of these businesses to unite their expertise to others and share from a unified gain. By combining the power of shared ideals and resources through joint ventures, we can move as larger more developed companies do, but without limiting quality and compassion for social and environmental governance."
With a focus on profitability and mutually beneficial cross points, MSRM is assessing partnerships with complimentary businesses which would strategically advance the Company's reach into related markets through joint ventures and M&A activity.
Establishing pillars of development outside of the industrial mushroom market allows for a broad scope of proven profitability and cross-sharing of resources.
We seek to enter partnerships in the Cultivation Market, which includes substrate, spawn production, and fruiting. Cultivation gives life to all market pillars to some degree. It feeds directly into the Mushroom Nutraceutical and Medicinal Psylocibin Market with the addition of extraction, quality testing, product development, and processing. The Medicinal Mushroom Market requires legalization and branches into wellness retreats, treatment certifications and clinics.
MSRM is also evaluating several companies involved in the Myco-Remediation Market which uses fungi to clean oil spills, heavy metals, plastics and other pollutants from soil, water, and the atmosphere. All of these markets relate to the industrial and health innovation that the Company is pursuing in differing aspects and creates a connecting point for acceleration, mutual benefit and market share.
It is the belief of MSRM that connecting these pillars of the mushroom market through joint ventures and acquisitions, while focusing their innovation efforts on the industrial side of the market, will garner cross benefits financially and accelerate timelines during the major research and development phases.
We are simultaneously creating a vertically integrated business model for the businesses involved by aligning strengths between the companies under the umbrella of MSRM.
From an investor perspective, we are creating an avenue for investors to support a larger portion of the mushroom market, establishing a broader financial base of support for and from the networked companies while allowing for a more elastic ability to pivot, expand and connect to new industry pathways as they surface.
Market Opportunity
Mushrooms, Inc. operates in the North American segment of the functional mushroom market in the mycelium material and mushroom supplement product types. According to various industrial research firms, the global functional mushroom market is projected to show a compounded annual growth rate of over 9% for the next five years (Industry Arc and Vantage Market Research). The North American edible mushroom market was worth 11.99 billion in 2023 and is growing at a compounded annual growth rate of 9.48%, forecast to reach 20.91 billion by 2028 (Market Data Forecast). The North American functional mushroom market held 33.8% of the global market in 2020 and is growing at a compounded annual growth rate of 7% (Industry Arc).
Overview
Mushrooms, Inc. is a developing-stage emerging consumer products platform focused on the manufacturing and marketing of highly differentiated mushroom-based materials and functional supplements. The core growth pillars of the Mushrooms, Inc. platform are currently based on developing functional mushroom technologies. As a result of growing consumer demand for innovative, sustainable, and carbon-neutral products, Mushrooms, Inc. plans to grow revenues by penetrating the multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology, as well as expanding our platform to include the creation of supplements based on the proven health benefits of mushrooms.
Mushrooms, Inc. seeks to drive the growth of the bourgeoning functional mushroom industry through product innovation and development. Our current core business activity is environmentally beneficial product innovation utilizing self-growing, fibrous, and natural composite materials with controlled physical properties that can be produced in large quantities. Our product technologies focus on mycelium, the main component of fungi. This emerging biotechnology is used in the creation of carbon neutral products for the building, textile, packaging, and health care industries, as well as in the creation of supplements based on the proven health benefits of mushrooms.
Currently, our research focuses primarily on the significant thermal stability of mycelium materials, a result of mycelium's unique degradation qualities that expand the potential fields of application for mushroom-based products. Mushrooms, Inc.'s long-term goal is to build a strong scalable and widely recognized brand that authentically focuses on sustainable mushroom ingredients and novel functionality stemming from innovative biotech and materials science.
For more information, email info@mushroomsinc.com or visit www.mushroomsinc.com
07/19/2023 Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast Press Release
02/23/2023 Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release
04/20/2023 Quarterly Report for the period ended March 31, 2023
03/06/2023 Attorney Letter with Respect to Current Information - Shell Status Opinion MSRM
03/06/2023 Attorney Letter with Respect to Current Information - MSRM - Current Information Letter
03/06/2023 Annual Report - MSRM 2022 Annual Report
11/29/2022 Mushrooms, Inc. Announces Name and Ticker Symbol Change on OTC Markets to “MSRM” Press Release
https://www.otcmarkets.com/stock/MSRM/disclosure
08/23/2022 Marijuana Strategic Ventures, Inc. (OTC: MSVI) Now Mushrooms Inc., Announces Filing of Provisional Patent for Novel Mycelium Thread Press Release
Outstanding Shares 38,485,760 07/18/2023
Restricted 32,527,735 07/18/2023
Unrestricted 5,958,025 07/18/2023
Authorized Shares 400,000,000 07/18/2023
update by CEO:
see twitter https://twitter.com/MushroomsInc
MSRM This is totally under the Radar and is REAL. Check the SS , they did file a Patent that is coming up , they do have the product and their Mgt Team actually knows what they are doing.
https://otcmarkets.com/stock/MSRM/security
https://mushroomsinc.com/team-3
https://twitter.com/MushroomsInc
MSRM
Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast.
Estero, FL, July 19, 2023 – Mushrooms Inc. (OTC: MSRM) (the “Company” or “MSRM) is pleased to announce that its CEO, Kimberly Carlson, recently appeared on the esteemed Psychedelic Spotlight Podcast to discuss the exciting potential of the industrial mushroom industry. As the first company trading on the US stock market focused on the industrial side of mushrooms, Mushrooms Inc. is leading the way in revolutionizing this emerging sector.
To watch or listen to the complete interview featuring Kimberly Carlson on Psychedelic Spotlight, please visit the following link: https://psychedelicspotlight.com/using-mycelium-for-a-sustainable-future-feat-kimberly-carlson/
During the podcast episode hosted by David Flores (CEO of Psychedelic Spotlight), Kimberly Carlson shared insights into the vision and mission of Mushrooms Inc. The Company is dedicated to supporting the growth of the mushroom industry through collaboration, innovation, and development. At the heart of Mushrooms Inc. lies a commitment to creating and supporting environmentally beneficial product innovation.
With a specific focus on the industrial application of mycelium, Mushrooms Inc. aims to develop carbon-neutral products for the building, textile, and healthcare industries. By harnessing the power of mycology, Mushrooms Inc. seeks to advance the creation of scientifically proven products that promote the health of the body, mind, and environment which includes remediation of toxic substances using mycelium also known as Myco-remediation.
Along with providing Mr. Flores with an overview of Mushrooms Inc., Ms. Carlson also shared insight into her own personal passion for working within the mushroom sector and why she believes mycelium holds the potential to promote a healthier and more sustainable environment for all of society.
"The potential of the industrial mushroom sector is immense, and Mushrooms Inc. is at the forefront of driving innovation in this field," said Kimberly Carlson, CEO of Mushrooms Inc. "Through our research and development efforts, we are committed to delivering sustainable solutions that benefit not only our customers but also the planet.
I am grateful for the opportunity to have had Mushrooms Inc. featured on the Psychedelic Spotlight Podcast, and more specifically, for the opportunity to provide their audience, as well as many others following the public markets, with an initial introduction into some the exiting things we have planned for MSRM.
In the weeks and months ahead, I look forward to being able to share some of the progress we anticipate making as we strive to truly position MSRM as an industrial mushroom leader.”
Mushrooms Inc. recognizes that true innovation comes from collaboration and learning from pioneers in the field. By fostering working relationships and engaging with experts in mycology, the Company is paving the way for groundbreaking advancements in the industry.
Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release | 02/23/2023
ESTERO, FL / ACCESSWIRE / February 23, 2023 / Mushrooms, Inc. (OTC PINK:MSRM) (the "Company") has been quietly making progress within this exciting multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology.
Mushrooms Inc. is developing profitable pathways to sustain the research and development branch which is necessary to achieve viable industrial innovation in this new field.
MSRM is targeting grants specific to their goals, working with pioneers, scientists, and universities, on a global scale to develop scientifically proven products that advance health of body, mind, and environment. They have multiple proposals that they are currently reviewing for their costs to bring to market, timelines, scalability, as well as their positive financial, environmental and health impact. These proposals include a patentable process for the development of mycelium-based building supplies, a patentable process for mushroom related cosmetic and anti-aging skin products, a superfood product not currently seen in the marketplace as well as several remediation projects with new product innovation as an end result. These proposals are being assessed while keeping the progress on an off-shore lab and scientists for an evolved patentable mycelium thread.
GROWTH STRATEGY
In order to offset research costs and time on the industrial development side we are establishing pillars of development outside of the industrial mushroom market through acquisitions and joint ventures. The business model is based on the amazing qualities of mycelium and its networking capabilities as well as its ability to benefit from the network its developing.
CEO Kimberly Carlson shared, "I have been fortunate to connect with amazing pioneers and innovators in differing areas of the Mushroom Market in the US and abroad. Three realities have been consistent with the people behind the businesses and their processes. One is that this business model can bring like-minded companies together in order to benefit and fruit from a shared network under the public umbrella. Secondly, there are natural and substantial cross-points between these companies to mutually benefit from each other while growing as a whole. And the third is that there is a desire for many of these businesses to unite their expertise to others and share from a unified gain. By combining the power of shared ideals and resources through joint ventures, we can move as larger more developed companies do, but without limiting quality and compassion for social and environmental governance."
With a focus on profitability and mutually beneficial cross points, MSRM is assessing partnerships with complimentary businesses which would strategically advance the Company's reach into related markets through joint ventures and M&A activity.
Establishing pillars of development outside of the industrial mushroom market allows for a broad scope of proven profitability and cross-sharing of resources.
We seek to enter partnerships in the Cultivation Market, which includes substrate, spawn production, and fruiting. Cultivation gives life to all market pillars to some degree. It feeds directly into the Mushroom Nutraceutical and Medicinal Psylocibin Market with the addition of extraction, quality testing, product development, and processing. The Medicinal Mushroom Market requires legalization and branches into wellness retreats, treatment certifications and clinics.
MSRM is also evaluating several companies involved in the Myco-Remediation Market which uses fungi to clean oil spills, heavy metals, plastics and other pollutants from soil, water, and the atmosphere. All of these markets relate to the industrial and health innovation that the Company is pursuing in differing aspects and creates a connecting point for acceleration, mutual benefit and market share.
It is the belief of MSRM that connecting these pillars of the mushroom market through joint ventures and acquisitions, while focusing their innovation efforts on the industrial side of the market, will garner cross benefits financially and accelerate timelines during the major research and development phases.
We are simultaneously creating a vertically integrated business model for the businesses involved by aligning strengths between the companies under the umbrella of MSRM.
From an investor perspective, we are creating an avenue for investors to support a larger portion of the mushroom market, establishing a broader financial base of support for and from the networked companies while allowing for a more elastic ability to pivot, expand and connect to new industry pathways as they surface.
Market Opportunity
Mushrooms, Inc. operates in the North American segment of the functional mushroom market in the mycelium material and mushroom supplement product types. According to various industrial research firms, the global functional mushroom market is projected to show a compounded annual growth rate of over 9% for the next five years (Industry Arc and Vantage Market Research). The North American edible mushroom market was worth 11.99 billion in 2023 and is growing at a compounded annual growth rate of 9.48%, forecast to reach 20.91 billion by 2028 (Market Data Forecast). The North American functional mushroom market held 33.8% of the global market in 2020 and is growing at a compounded annual growth rate of 7% (Industry Arc).
Overview
Mushrooms, Inc. is a developing-stage emerging consumer products platform focused on the manufacturing and marketing of highly differentiated mushroom-based materials and functional supplements. The core growth pillars of the Mushrooms, Inc. platform are currently based on developing functional mushroom technologies. As a result of growing consumer demand for innovative, sustainable, and carbon-neutral products, Mushrooms, Inc. plans to grow revenues by penetrating the multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology, as well as expanding our platform to include the creation of supplements based on the proven health benefits of mushrooms.
Mushrooms, Inc. seeks to drive the growth of the bourgeoning functional mushroom industry through product innovation and development. Our current core business activity is environmentally beneficial product innovation utilizing self-growing, fibrous, and natural composite materials with controlled physical properties that can be produced in large quantities. Our product technologies focus on mycelium, the main component of fungi. This emerging biotechnology is used in the creation of carbon neutral products for the building, textile, packaging, and health care industries, as well as in the creation of supplements based on the proven health benefits of mushrooms.
Currently, our research focuses primarily on the significant thermal stability of mycelium materials, a result of mycelium's unique degradation qualities that expand the potential fields of application for mushroom-based products. Mushrooms, Inc.'s long-term goal is to build a strong scalable and widely recognized brand that authentically focuses on sustainable mushroom ingredients and novel functionality stemming from innovative biotech and materials science.
For more information, email info@mushroomsinc.com or visit www.mushroomsinc.com
07/19/2023 Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast Press Release
02/23/2023 Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release
04/20/2023 Quarterly Report for the period ended March 31, 2023
03/06/2023 Attorney Letter with Respect to Current Information - Shell Status Opinion MSRM
03/06/2023 Attorney Letter with Respect to Current Information - MSRM - Current Information Letter
03/06/2023 Annual Report - MSRM 2022 Annual Report
11/29/2022 Mushrooms, Inc. Announces Name and Ticker Symbol Change on OTC Markets to “MSRM” Press Release
https://www.otcmarkets.com/stock/MSRM/disclosure
08/23/2022 Marijuana Strategic Ventures, Inc. (OTC: MSVI) Now Mushrooms Inc., Announces Filing of Provisional Patent for Novel Mycelium Thread Press Release
Outstanding Shares 38,485,760 07/18/2023
Restricted 32,527,735 07/18/2023
Unrestricted 5,958,025 07/18/2023
Authorized Shares 400,000,000 07/18/2023
update by CEO:
see twitter https://twitter.com/MushroomsInc
MSRM This is totally under the Radar and is REAL. Check the SS , they did file a Patent that is coming up , they do have the product and their Mgt Team actually knows what they are doing.
https://otcmarkets.com/stock/MSRM/security
https://mushroomsinc.com/team-3
https://twitter.com/MushroomsInc
i]
MSRM
Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast.
Estero, FL, July 19, 2023 – Mushrooms Inc. (OTC: MSRM) (the “Company” or “MSRM) is pleased to announce that its CEO, Kimberly Carlson, recently appeared on the esteemed Psychedelic Spotlight Podcast to discuss the exciting potential of the industrial mushroom industry. As the first company trading on the US stock market focused on the industrial side of mushrooms, Mushrooms Inc. is leading the way in revolutionizing this emerging sector.
To watch or listen to the complete interview featuring Kimberly Carlson on Psychedelic Spotlight, please visit the following link: https://psychedelicspotlight.com/using-mycelium-for-a-sustainable-future-feat-kimberly-carlson/
During the podcast episode hosted by David Flores (CEO of Psychedelic Spotlight), Kimberly Carlson shared insights into the vision and mission of Mushrooms Inc. The Company is dedicated to supporting the growth of the mushroom industry through collaboration, innovation, and development. At the heart of Mushrooms Inc. lies a commitment to creating and supporting environmentally beneficial product innovation.
With a specific focus on the industrial application of mycelium, Mushrooms Inc. aims to develop carbon-neutral products for the building, textile, and healthcare industries. By harnessing the power of mycology, Mushrooms Inc. seeks to advance the creation of scientifically proven products that promote the health of the body, mind, and environment which includes remediation of toxic substances using mycelium also known as Myco-remediation.
Along with providing Mr. Flores with an overview of Mushrooms Inc., Ms. Carlson also shared insight into her own personal passion for working within the mushroom sector and why she believes mycelium holds the potential to promote a healthier and more sustainable environment for all of society.
"The potential of the industrial mushroom sector is immense, and Mushrooms Inc. is at the forefront of driving innovation in this field," said Kimberly Carlson, CEO of Mushrooms Inc. "Through our research and development efforts, we are committed to delivering sustainable solutions that benefit not only our customers but also the planet.
I am grateful for the opportunity to have had Mushrooms Inc. featured on the Psychedelic Spotlight Podcast, and more specifically, for the opportunity to provide their audience, as well as many others following the public markets, with an initial introduction into some the exiting things we have planned for MSRM.
In the weeks and months ahead, I look forward to being able to share some of the progress we anticipate making as we strive to truly position MSRM as an industrial mushroom leader.”
Mushrooms Inc. recognizes that true innovation comes from collaboration and learning from pioneers in the field. By fostering working relationships and engaging with experts in mycology, the Company is paving the way for groundbreaking advancements in the industry.
Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release | 02/23/2023
ESTERO, FL / ACCESSWIRE / February 23, 2023 / Mushrooms, Inc. (OTC PINK:MSRM) (the "Company") has been quietly making progress within this exciting multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology.
Mushrooms Inc. is developing profitable pathways to sustain the research and development branch which is necessary to achieve viable industrial innovation in this new field.
MSRM is targeting grants specific to their goals, working with pioneers, scientists, and universities, on a global scale to develop scientifically proven products that advance health of body, mind, and environment. They have multiple proposals that they are currently reviewing for their costs to bring to market, timelines, scalability, as well as their positive financial, environmental and health impact. These proposals include a patentable process for the development of mycelium-based building supplies, a patentable process for mushroom related cosmetic and anti-aging skin products, a superfood product not currently seen in the marketplace as well as several remediation projects with new product innovation as an end result. These proposals are being assessed while keeping the progress on an off-shore lab and scientists for an evolved patentable mycelium thread.
GROWTH STRATEGY
In order to offset research costs and time on the industrial development side we are establishing pillars of development outside of the industrial mushroom market through acquisitions and joint ventures. The business model is based on the amazing qualities of mycelium and its networking capabilities as well as its ability to benefit from the network its developing.
CEO Kimberly Carlson shared, "I have been fortunate to connect with amazing pioneers and innovators in differing areas of the Mushroom Market in the US and abroad. Three realities have been consistent with the people behind the businesses and their processes. One is that this business model can bring like-minded companies together in order to benefit and fruit from a shared network under the public umbrella. Secondly, there are natural and substantial cross-points between these companies to mutually benefit from each other while growing as a whole. And the third is that there is a desire for many of these businesses to unite their expertise to others and share from a unified gain. By combining the power of shared ideals and resources through joint ventures, we can move as larger more developed companies do, but without limiting quality and compassion for social and environmental governance."
With a focus on profitability and mutually beneficial cross points, MSRM is assessing partnerships with complimentary businesses which would strategically advance the Company's reach into related markets through joint ventures and M&A activity.
Establishing pillars of development outside of the industrial mushroom market allows for a broad scope of proven profitability and cross-sharing of resources.
We seek to enter partnerships in the Cultivation Market, which includes substrate, spawn production, and fruiting. Cultivation gives life to all market pillars to some degree. It feeds directly into the Mushroom Nutraceutical and Medicinal Psylocibin Market with the addition of extraction, quality testing, product development, and processing. The Medicinal Mushroom Market requires legalization and branches into wellness retreats, treatment certifications and clinics.
MSRM is also evaluating several companies involved in the Myco-Remediation Market which uses fungi to clean oil spills, heavy metals, plastics and other pollutants from soil, water, and the atmosphere. All of these markets relate to the industrial and health innovation that the Company is pursuing in differing aspects and creates a connecting point for acceleration, mutual benefit and market share.
It is the belief of MSRM that connecting these pillars of the mushroom market through joint ventures and acquisitions, while focusing their innovation efforts on the industrial side of the market, will garner cross benefits financially and accelerate timelines during the major research and development phases.
We are simultaneously creating a vertically integrated business model for the businesses involved by aligning strengths between the companies under the umbrella of MSRM.
From an investor perspective, we are creating an avenue for investors to support a larger portion of the mushroom market, establishing a broader financial base of support for and from the networked companies while allowing for a more elastic ability to pivot, expand and connect to new industry pathways as they surface.
Market Opportunity
Mushrooms, Inc. operates in the North American segment of the functional mushroom market in the mycelium material and mushroom supplement product types. According to various industrial research firms, the global functional mushroom market is projected to show a compounded annual growth rate of over 9% for the next five years (Industry Arc and Vantage Market Research). The North American edible mushroom market was worth 11.99 billion in 2023 and is growing at a compounded annual growth rate of 9.48%, forecast to reach 20.91 billion by 2028 (Market Data Forecast). The North American functional mushroom market held 33.8% of the global market in 2020 and is growing at a compounded annual growth rate of 7% (Industry Arc).
Overview
Mushrooms, Inc. is a developing-stage emerging consumer products platform focused on the manufacturing and marketing of highly differentiated mushroom-based materials and functional supplements. The core growth pillars of the Mushrooms, Inc. platform are currently based on developing functional mushroom technologies. As a result of growing consumer demand for innovative, sustainable, and carbon-neutral products, Mushrooms, Inc. plans to grow revenues by penetrating the multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology, as well as expanding our platform to include the creation of supplements based on the proven health benefits of mushrooms.
Mushrooms, Inc. seeks to drive the growth of the bourgeoning functional mushroom industry through product innovation and development. Our current core business activity is environmentally beneficial product innovation utilizing self-growing, fibrous, and natural composite materials with controlled physical properties that can be produced in large quantities. Our product technologies focus on mycelium, the main component of fungi. This emerging biotechnology is used in the creation of carbon neutral products for the building, textile, packaging, and health care industries, as well as in the creation of supplements based on the proven health benefits of mushrooms.
Currently, our research focuses primarily on the significant thermal stability of mycelium materials, a result of mycelium's unique degradation qualities that expand the potential fields of application for mushroom-based products. Mushrooms, Inc.'s long-term goal is to build a strong scalable and widely recognized brand that authentically focuses on sustainable mushroom ingredients and novel functionality stemming from innovative biotech and materials science.
For more information, email info@mushroomsinc.com or visit www.mushroomsinc.com
07/19/2023 Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast Press Release
02/23/2023 Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release
04/20/2023 Quarterly Report for the period ended March 31, 2023
03/06/2023 Attorney Letter with Respect to Current Information - Shell Status Opinion MSRM
03/06/2023 Attorney Letter with Respect to Current Information - MSRM - Current Information Letter
03/06/2023 Annual Report - MSRM 2022 Annual Report
11/29/2022 Mushrooms, Inc. Announces Name and Ticker Symbol Change on OTC Markets to “MSRM” Press Release
https://www.otcmarkets.com/stock/MSRM/disclosure
08/23/2022 Marijuana Strategic Ventures, Inc. (OTC: MSVI) Now Mushrooms Inc., Announces Filing of Provisional Patent for Novel Mycelium Thread Press Release
Outstanding Shares 38,485,760 07/18/2023
Restricted 32,527,735 07/18/2023
Unrestricted 5,958,025 07/18/2023
Authorized Shares 400,000,000 07/18/2023
update by CEO:
see twitter https://twitter.com/MushroomsInc
MSRM This is totally under the Radar and is REAL. Check the SS , they did file a Patent that is coming up , they do have the product and their Mgt Team actually knows what they are doing.
https://otcmarkets.com/stock/MSRM/security
https://mushroomsinc.com/team-3
https://twitter.com/MushroomsInc
i]
MSRM updates and podcast..Unrestricted shares preserved at 6M
Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast.
Estero, FL, July 19, 2023 – Mushrooms Inc. (OTC: MSRM) (the “Company” or “MSRM) is pleased to announce that its CEO, Kimberly Carlson, recently appeared on the esteemed Psychedelic Spotlight Podcast to discuss the exciting potential of the industrial mushroom industry. As the first company trading on the US stock market focused on the industrial side of mushrooms, Mushrooms Inc. is leading the way in revolutionizing this emerging sector.
To watch or listen to the complete interview featuring Kimberly Carlson on Psychedelic Spotlight, please visit the following link: https://psychedelicspotlight.com/using-mycelium-for-a-sustainable-future-feat-kimberly-carlson/
During the podcast episode hosted by David Flores (CEO of Psychedelic Spotlight), Kimberly Carlson shared insights into the vision and mission of Mushrooms Inc. The Company is dedicated to supporting the growth of the mushroom industry through collaboration, innovation, and development. At the heart of Mushrooms Inc. lies a commitment to creating and supporting environmentally beneficial product innovation.
With a specific focus on the industrial application of mycelium, Mushrooms Inc. aims to develop carbon-neutral products for the building, textile, and healthcare industries. By harnessing the power of mycology, Mushrooms Inc. seeks to advance the creation of scientifically proven products that promote the health of the body, mind, and environment which includes remediation of toxic substances using mycelium also known as Myco-remediation.
Along with providing Mr. Flores with an overview of Mushrooms Inc., Ms. Carlson also shared insight into her own personal passion for working within the mushroom sector and why she believes mycelium holds the potential to promote a healthier and more sustainable environment for all of society.
"The potential of the industrial mushroom sector is immense, and Mushrooms Inc. is at the forefront of driving innovation in this field," said Kimberly Carlson, CEO of Mushrooms Inc. "Through our research and development efforts, we are committed to delivering sustainable solutions that benefit not only our customers but also the planet.
I am grateful for the opportunity to have had Mushrooms Inc. featured on the Psychedelic Spotlight Podcast, and more specifically, for the opportunity to provide their audience, as well as many others following the public markets, with an initial introduction into some the exiting things we have planned for MSRM.
In the weeks and months ahead, I look forward to being able to share some of the progress we anticipate making as we strive to truly position MSRM as an industrial mushroom leader.”
Mushrooms Inc. recognizes that true innovation comes from collaboration and learning from pioneers in the field. By fostering working relationships and engaging with experts in mycology, the Company is paving the way for groundbreaking advancements in the industry.
Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release | 02/23/2023
ESTERO, FL / ACCESSWIRE / February 23, 2023 / Mushrooms, Inc. (OTC PINK:MSRM) (the "Company") has been quietly making progress within this exciting multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology.
Mushrooms Inc. is developing profitable pathways to sustain the research and development branch which is necessary to achieve viable industrial innovation in this new field.
MSRM is targeting grants specific to their goals, working with pioneers, scientists, and universities, on a global scale to develop scientifically proven products that advance health of body, mind, and environment. They have multiple proposals that they are currently reviewing for their costs to bring to market, timelines, scalability, as well as their positive financial, environmental and health impact. These proposals include a patentable process for the development of mycelium-based building supplies, a patentable process for mushroom related cosmetic and anti-aging skin products, a superfood product not currently seen in the marketplace as well as several remediation projects with new product innovation as an end result. These proposals are being assessed while keeping the progress on an off-shore lab and scientists for an evolved patentable mycelium thread.
GROWTH STRATEGY
In order to offset research costs and time on the industrial development side we are establishing pillars of development outside of the industrial mushroom market through acquisitions and joint ventures. The business model is based on the amazing qualities of mycelium and its networking capabilities as well as its ability to benefit from the network its developing.
CEO Kimberly Carlson shared, "I have been fortunate to connect with amazing pioneers and innovators in differing areas of the Mushroom Market in the US and abroad. Three realities have been consistent with the people behind the businesses and their processes. One is that this business model can bring like-minded companies together in order to benefit and fruit from a shared network under the public umbrella. Secondly, there are natural and substantial cross-points between these companies to mutually benefit from each other while growing as a whole. And the third is that there is a desire for many of these businesses to unite their expertise to others and share from a unified gain. By combining the power of shared ideals and resources through joint ventures, we can move as larger more developed companies do, but without limiting quality and compassion for social and environmental governance."
With a focus on profitability and mutually beneficial cross points, MSRM is assessing partnerships with complimentary businesses which would strategically advance the Company's reach into related markets through joint ventures and M&A activity.
Establishing pillars of development outside of the industrial mushroom market allows for a broad scope of proven profitability and cross-sharing of resources.
We seek to enter partnerships in the Cultivation Market, which includes substrate, spawn production, and fruiting. Cultivation gives life to all market pillars to some degree. It feeds directly into the Mushroom Nutraceutical and Medicinal Psylocibin Market with the addition of extraction, quality testing, product development, and processing. The Medicinal Mushroom Market requires legalization and branches into wellness retreats, treatment certifications and clinics.
MSRM is also evaluating several companies involved in the Myco-Remediation Market which uses fungi to clean oil spills, heavy metals, plastics and other pollutants from soil, water, and the atmosphere. All of these markets relate to the industrial and health innovation that the Company is pursuing in differing aspects and creates a connecting point for acceleration, mutual benefit and market share.
It is the belief of MSRM that connecting these pillars of the mushroom market through joint ventures and acquisitions, while focusing their innovation efforts on the industrial side of the market, will garner cross benefits financially and accelerate timelines during the major research and development phases.
We are simultaneously creating a vertically integrated business model for the businesses involved by aligning strengths between the companies under the umbrella of MSRM.
From an investor perspective, we are creating an avenue for investors to support a larger portion of the mushroom market, establishing a broader financial base of support for and from the networked companies while allowing for a more elastic ability to pivot, expand and connect to new industry pathways as they surface.
Market Opportunity
Mushrooms, Inc. operates in the North American segment of the functional mushroom market in the mycelium material and mushroom supplement product types. According to various industrial research firms, the global functional mushroom market is projected to show a compounded annual growth rate of over 9% for the next five years (Industry Arc and Vantage Market Research). The North American edible mushroom market was worth 11.99 billion in 2023 and is growing at a compounded annual growth rate of 9.48%, forecast to reach 20.91 billion by 2028 (Market Data Forecast). The North American functional mushroom market held 33.8% of the global market in 2020 and is growing at a compounded annual growth rate of 7% (Industry Arc).
Overview
Mushrooms, Inc. is a developing-stage emerging consumer products platform focused on the manufacturing and marketing of highly differentiated mushroom-based materials and functional supplements. The core growth pillars of the Mushrooms, Inc. platform are currently based on developing functional mushroom technologies. As a result of growing consumer demand for innovative, sustainable, and carbon-neutral products, Mushrooms, Inc. plans to grow revenues by penetrating the multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology, as well as expanding our platform to include the creation of supplements based on the proven health benefits of mushrooms.
Mushrooms, Inc. seeks to drive the growth of the bourgeoning functional mushroom industry through product innovation and development. Our current core business activity is environmentally beneficial product innovation utilizing self-growing, fibrous, and natural composite materials with controlled physical properties that can be produced in large quantities. Our product technologies focus on mycelium, the main component of fungi. This emerging biotechnology is used in the creation of carbon neutral products for the building, textile, packaging, and health care industries, as well as in the creation of supplements based on the proven health benefits of mushrooms.
Currently, our research focuses primarily on the significant thermal stability of mycelium materials, a result of mycelium's unique degradation qualities that expand the potential fields of application for mushroom-based products. Mushrooms, Inc.'s long-term goal is to build a strong scalable and widely recognized brand that authentically focuses on sustainable mushroom ingredients and novel functionality stemming from innovative biotech and materials science.
For more information, email info@mushroomsinc.com or visit www.mushroomsinc.com
07/19/2023 Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast Press Release
02/23/2023 Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release
04/20/2023 Quarterly Report for the period ended March 31, 2023
03/06/2023 Attorney Letter with Respect to Current Information - Shell Status Opinion MSRM
03/06/2023 Attorney Letter with Respect to Current Information - MSRM - Current Information Letter
03/06/2023 Annual Report - MSRM 2022 Annual Report
11/29/2022 Mushrooms, Inc. Announces Name and Ticker Symbol Change on OTC Markets to “MSRM” Press Release
https://www.otcmarkets.com/stock/MSRM/disclosure
08/23/2022 Marijuana Strategic Ventures, Inc. (OTC: MSVI) Now Mushrooms Inc., Announces Filing of Provisional Patent for Novel Mycelium Thread Press Release
Outstanding Shares 38,485,760 07/18/2023
Restricted 32,527,735 07/18/2023
Unrestricted 5,958,025 07/18/2023
Authorized Shares 400,000,000 07/18/2023
update by CEO:
see twitter https://twitter.com/MushroomsInc
MSRM This is totally under the Radar and is REAL. Check the SS , they did file a Patent that is coming up , they do have the product and their Mgt Team actually knows what they are doing.
https://otcmarkets.com/stock/MSRM/security
https://mushroomsinc.com/team-3
https://twitter.com/MushroomsInc
MSRM updates and podcast..Unrestricted shares preserved at 6M
Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast.
Estero, FL, July 19, 2023 – Mushrooms Inc. (OTC: MSRM) (the “Company” or “MSRM) is pleased to announce that its CEO, Kimberly Carlson, recently appeared on the esteemed Psychedelic Spotlight Podcast to discuss the exciting potential of the industrial mushroom industry. As the first company trading on the US stock market focused on the industrial side of mushrooms, Mushrooms Inc. is leading the way in revolutionizing this emerging sector.
To watch or listen to the complete interview featuring Kimberly Carlson on Psychedelic Spotlight, please visit the following link: https://psychedelicspotlight.com/using-mycelium-for-a-sustainable-future-feat-kimberly-carlson/
During the podcast episode hosted by David Flores (CEO of Psychedelic Spotlight), Kimberly Carlson shared insights into the vision and mission of Mushrooms Inc. The Company is dedicated to supporting the growth of the mushroom industry through collaboration, innovation, and development. At the heart of Mushrooms Inc. lies a commitment to creating and supporting environmentally beneficial product innovation.
With a specific focus on the industrial application of mycelium, Mushrooms Inc. aims to develop carbon-neutral products for the building, textile, and healthcare industries. By harnessing the power of mycology, Mushrooms Inc. seeks to advance the creation of scientifically proven products that promote the health of the body, mind, and environment which includes remediation of toxic substances using mycelium also known as Myco-remediation.
Along with providing Mr. Flores with an overview of Mushrooms Inc., Ms. Carlson also shared insight into her own personal passion for working within the mushroom sector and why she believes mycelium holds the potential to promote a healthier and more sustainable environment for all of society.
"The potential of the industrial mushroom sector is immense, and Mushrooms Inc. is at the forefront of driving innovation in this field," said Kimberly Carlson, CEO of Mushrooms Inc. "Through our research and development efforts, we are committed to delivering sustainable solutions that benefit not only our customers but also the planet.
I am grateful for the opportunity to have had Mushrooms Inc. featured on the Psychedelic Spotlight Podcast, and more specifically, for the opportunity to provide their audience, as well as many others following the public markets, with an initial introduction into some the exiting things we have planned for MSRM.
In the weeks and months ahead, I look forward to being able to share some of the progress we anticipate making as we strive to truly position MSRM as an industrial mushroom leader.”
Mushrooms Inc. recognizes that true innovation comes from collaboration and learning from pioneers in the field. By fostering working relationships and engaging with experts in mycology, the Company is paving the way for groundbreaking advancements in the industry.
Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release | 02/23/2023
ESTERO, FL / ACCESSWIRE / February 23, 2023 / Mushrooms, Inc. (OTC PINK:MSRM) (the "Company") has been quietly making progress within this exciting multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology.
Mushrooms Inc. is developing profitable pathways to sustain the research and development branch which is necessary to achieve viable industrial innovation in this new field.
MSRM is targeting grants specific to their goals, working with pioneers, scientists, and universities, on a global scale to develop scientifically proven products that advance health of body, mind, and environment. They have multiple proposals that they are currently reviewing for their costs to bring to market, timelines, scalability, as well as their positive financial, environmental and health impact. These proposals include a patentable process for the development of mycelium-based building supplies, a patentable process for mushroom related cosmetic and anti-aging skin products, a superfood product not currently seen in the marketplace as well as several remediation projects with new product innovation as an end result. These proposals are being assessed while keeping the progress on an off-shore lab and scientists for an evolved patentable mycelium thread.
GROWTH STRATEGY
In order to offset research costs and time on the industrial development side we are establishing pillars of development outside of the industrial mushroom market through acquisitions and joint ventures. The business model is based on the amazing qualities of mycelium and its networking capabilities as well as its ability to benefit from the network its developing.
CEO Kimberly Carlson shared, "I have been fortunate to connect with amazing pioneers and innovators in differing areas of the Mushroom Market in the US and abroad. Three realities have been consistent with the people behind the businesses and their processes. One is that this business model can bring like-minded companies together in order to benefit and fruit from a shared network under the public umbrella. Secondly, there are natural and substantial cross-points between these companies to mutually benefit from each other while growing as a whole. And the third is that there is a desire for many of these businesses to unite their expertise to others and share from a unified gain. By combining the power of shared ideals and resources through joint ventures, we can move as larger more developed companies do, but without limiting quality and compassion for social and environmental governance."
With a focus on profitability and mutually beneficial cross points, MSRM is assessing partnerships with complimentary businesses which would strategically advance the Company's reach into related markets through joint ventures and M&A activity.
Establishing pillars of development outside of the industrial mushroom market allows for a broad scope of proven profitability and cross-sharing of resources.
We seek to enter partnerships in the Cultivation Market, which includes substrate, spawn production, and fruiting. Cultivation gives life to all market pillars to some degree. It feeds directly into the Mushroom Nutraceutical and Medicinal Psylocibin Market with the addition of extraction, quality testing, product development, and processing. The Medicinal Mushroom Market requires legalization and branches into wellness retreats, treatment certifications and clinics.
MSRM is also evaluating several companies involved in the Myco-Remediation Market which uses fungi to clean oil spills, heavy metals, plastics and other pollutants from soil, water, and the atmosphere. All of these markets relate to the industrial and health innovation that the Company is pursuing in differing aspects and creates a connecting point for acceleration, mutual benefit and market share.
It is the belief of MSRM that connecting these pillars of the mushroom market through joint ventures and acquisitions, while focusing their innovation efforts on the industrial side of the market, will garner cross benefits financially and accelerate timelines during the major research and development phases.
We are simultaneously creating a vertically integrated business model for the businesses involved by aligning strengths between the companies under the umbrella of MSRM.
From an investor perspective, we are creating an avenue for investors to support a larger portion of the mushroom market, establishing a broader financial base of support for and from the networked companies while allowing for a more elastic ability to pivot, expand and connect to new industry pathways as they surface.
Market Opportunity
Mushrooms, Inc. operates in the North American segment of the functional mushroom market in the mycelium material and mushroom supplement product types. According to various industrial research firms, the global functional mushroom market is projected to show a compounded annual growth rate of over 9% for the next five years (Industry Arc and Vantage Market Research). The North American edible mushroom market was worth 11.99 billion in 2023 and is growing at a compounded annual growth rate of 9.48%, forecast to reach 20.91 billion by 2028 (Market Data Forecast). The North American functional mushroom market held 33.8% of the global market in 2020 and is growing at a compounded annual growth rate of 7% (Industry Arc).
Overview
Mushrooms, Inc. is a developing-stage emerging consumer products platform focused on the manufacturing and marketing of highly differentiated mushroom-based materials and functional supplements. The core growth pillars of the Mushrooms, Inc. platform are currently based on developing functional mushroom technologies. As a result of growing consumer demand for innovative, sustainable, and carbon-neutral products, Mushrooms, Inc. plans to grow revenues by penetrating the multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology, as well as expanding our platform to include the creation of supplements based on the proven health benefits of mushrooms.
Mushrooms, Inc. seeks to drive the growth of the bourgeoning functional mushroom industry through product innovation and development. Our current core business activity is environmentally beneficial product innovation utilizing self-growing, fibrous, and natural composite materials with controlled physical properties that can be produced in large quantities. Our product technologies focus on mycelium, the main component of fungi. This emerging biotechnology is used in the creation of carbon neutral products for the building, textile, packaging, and health care industries, as well as in the creation of supplements based on the proven health benefits of mushrooms.
Currently, our research focuses primarily on the significant thermal stability of mycelium materials, a result of mycelium's unique degradation qualities that expand the potential fields of application for mushroom-based products. Mushrooms, Inc.'s long-term goal is to build a strong scalable and widely recognized brand that authentically focuses on sustainable mushroom ingredients and novel functionality stemming from innovative biotech and materials science.
For more information, email info@mushroomsinc.com or visit www.mushroomsinc.com
07/19/2023 Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast Press Release
02/23/2023 Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release
04/20/2023 Quarterly Report for the period ended March 31, 2023
03/06/2023 Attorney Letter with Respect to Current Information - Shell Status Opinion MSRM
03/06/2023 Attorney Letter with Respect to Current Information - MSRM - Current Information Letter
03/06/2023 Annual Report - MSRM 2022 Annual Report
11/29/2022 Mushrooms, Inc. Announces Name and Ticker Symbol Change on OTC Markets to “MSRM” Press Release
https://www.otcmarkets.com/stock/MSRM/disclosure
08/23/2022 Marijuana Strategic Ventures, Inc. (OTC: MSVI) Now Mushrooms Inc., Announces Filing of Provisional Patent for Novel Mycelium Thread Press Release
Outstanding Shares 38,485,760 07/18/2023
Restricted 32,527,735 07/18/2023
Unrestricted 5,958,025 07/18/2023
Authorized Shares 400,000,000 07/18/2023
update by CEO:
see twitter https://twitter.com/MushroomsInc
MSRM This is totally under the Radar and is REAL. Check the SS , they did file a Patent that is coming up , they do have the product and their Mgt Team actually knows what they are doing.
https://otcmarkets.com/stock/MSRM/security
https://mushroomsinc.com/team-3
https://twitter.com/MushroomsInc
MSRM bottom entry/low floater: Update & Acquisitions...Unrestricted shares preserved at 6M
Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast.
Estero, FL, July 19, 2023 – Mushrooms Inc. (OTC: MSRM) (the “Company” or “MSRM) is pleased to announce that its CEO, Kimberly Carlson, recently appeared on the esteemed Psychedelic Spotlight Podcast to discuss the exciting potential of the industrial mushroom industry. As the first company trading on the US stock market focused on the industrial side of mushrooms, Mushrooms Inc. is leading the way in revolutionizing this emerging sector.
To watch or listen to the complete interview featuring Kimberly Carlson on Psychedelic Spotlight, please visit the following link: https://psychedelicspotlight.com/using-mycelium-for-a-sustainable-future-feat-kimberly-carlson/
During the podcast episode hosted by David Flores (CEO of Psychedelic Spotlight), Kimberly Carlson shared insights into the vision and mission of Mushrooms Inc. The Company is dedicated to supporting the growth of the mushroom industry through collaboration, innovation, and development. At the heart of Mushrooms Inc. lies a commitment to creating and supporting environmentally beneficial product innovation.
With a specific focus on the industrial application of mycelium, Mushrooms Inc. aims to develop carbon-neutral products for the building, textile, and healthcare industries. By harnessing the power of mycology, Mushrooms Inc. seeks to advance the creation of scientifically proven products that promote the health of the body, mind, and environment which includes remediation of toxic substances using mycelium also known as Myco-remediation.
Along with providing Mr. Flores with an overview of Mushrooms Inc., Ms. Carlson also shared insight into her own personal passion for working within the mushroom sector and why she believes mycelium holds the potential to promote a healthier and more sustainable environment for all of society.
"The potential of the industrial mushroom sector is immense, and Mushrooms Inc. is at the forefront of driving innovation in this field," said Kimberly Carlson, CEO of Mushrooms Inc. "Through our research and development efforts, we are committed to delivering sustainable solutions that benefit not only our customers but also the planet.
I am grateful for the opportunity to have had Mushrooms Inc. featured on the Psychedelic Spotlight Podcast, and more specifically, for the opportunity to provide their audience, as well as many others following the public markets, with an initial introduction into some the exiting things we have planned for MSRM.
In the weeks and months ahead, I look forward to being able to share some of the progress we anticipate making as we strive to truly position MSRM as an industrial mushroom leader.”
Mushrooms Inc. recognizes that true innovation comes from collaboration and learning from pioneers in the field. By fostering working relationships and engaging with experts in mycology, the Company is paving the way for groundbreaking advancements in the industry.
Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release | 02/23/2023
ESTERO, FL / ACCESSWIRE / February 23, 2023 / Mushrooms, Inc. (OTC PINK:MSRM) (the "Company") has been quietly making progress within this exciting multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology.
Mushrooms Inc. is developing profitable pathways to sustain the research and development branch which is necessary to achieve viable industrial innovation in this new field.
MSRM is targeting grants specific to their goals, working with pioneers, scientists, and universities, on a global scale to develop scientifically proven products that advance health of body, mind, and environment. They have multiple proposals that they are currently reviewing for their costs to bring to market, timelines, scalability, as well as their positive financial, environmental and health impact. These proposals include a patentable process for the development of mycelium-based building supplies, a patentable process for mushroom related cosmetic and anti-aging skin products, a superfood product not currently seen in the marketplace as well as several remediation projects with new product innovation as an end result. These proposals are being assessed while keeping the progress on an off-shore lab and scientists for an evolved patentable mycelium thread.
GROWTH STRATEGY
In order to offset research costs and time on the industrial development side we are establishing pillars of development outside of the industrial mushroom market through acquisitions and joint ventures. The business model is based on the amazing qualities of mycelium and its networking capabilities as well as its ability to benefit from the network its developing.
CEO Kimberly Carlson shared, "I have been fortunate to connect with amazing pioneers and innovators in differing areas of the Mushroom Market in the US and abroad. Three realities have been consistent with the people behind the businesses and their processes. One is that this business model can bring like-minded companies together in order to benefit and fruit from a shared network under the public umbrella. Secondly, there are natural and substantial cross-points between these companies to mutually benefit from each other while growing as a whole. And the third is that there is a desire for many of these businesses to unite their expertise to others and share from a unified gain. By combining the power of shared ideals and resources through joint ventures, we can move as larger more developed companies do, but without limiting quality and compassion for social and environmental governance."
With a focus on profitability and mutually beneficial cross points, MSRM is assessing partnerships with complimentary businesses which would strategically advance the Company's reach into related markets through joint ventures and M&A activity.
Establishing pillars of development outside of the industrial mushroom market allows for a broad scope of proven profitability and cross-sharing of resources.
We seek to enter partnerships in the Cultivation Market, which includes substrate, spawn production, and fruiting. Cultivation gives life to all market pillars to some degree. It feeds directly into the Mushroom Nutraceutical and Medicinal Psylocibin Market with the addition of extraction, quality testing, product development, and processing. The Medicinal Mushroom Market requires legalization and branches into wellness retreats, treatment certifications and clinics.
MSRM is also evaluating several companies involved in the Myco-Remediation Market which uses fungi to clean oil spills, heavy metals, plastics and other pollutants from soil, water, and the atmosphere. All of these markets relate to the industrial and health innovation that the Company is pursuing in differing aspects and creates a connecting point for acceleration, mutual benefit and market share.
It is the belief of MSRM that connecting these pillars of the mushroom market through joint ventures and acquisitions, while focusing their innovation efforts on the industrial side of the market, will garner cross benefits financially and accelerate timelines during the major research and development phases.
We are simultaneously creating a vertically integrated business model for the businesses involved by aligning strengths between the companies under the umbrella of MSRM.
From an investor perspective, we are creating an avenue for investors to support a larger portion of the mushroom market, establishing a broader financial base of support for and from the networked companies while allowing for a more elastic ability to pivot, expand and connect to new industry pathways as they surface.
Market Opportunity
Mushrooms, Inc. operates in the North American segment of the functional mushroom market in the mycelium material and mushroom supplement product types. According to various industrial research firms, the global functional mushroom market is projected to show a compounded annual growth rate of over 9% for the next five years (Industry Arc and Vantage Market Research). The North American edible mushroom market was worth 11.99 billion in 2023 and is growing at a compounded annual growth rate of 9.48%, forecast to reach 20.91 billion by 2028 (Market Data Forecast). The North American functional mushroom market held 33.8% of the global market in 2020 and is growing at a compounded annual growth rate of 7% (Industry Arc).
Overview
Mushrooms, Inc. is a developing-stage emerging consumer products platform focused on the manufacturing and marketing of highly differentiated mushroom-based materials and functional supplements. The core growth pillars of the Mushrooms, Inc. platform are currently based on developing functional mushroom technologies. As a result of growing consumer demand for innovative, sustainable, and carbon-neutral products, Mushrooms, Inc. plans to grow revenues by penetrating the multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology, as well as expanding our platform to include the creation of supplements based on the proven health benefits of mushrooms.
Mushrooms, Inc. seeks to drive the growth of the bourgeoning functional mushroom industry through product innovation and development. Our current core business activity is environmentally beneficial product innovation utilizing self-growing, fibrous, and natural composite materials with controlled physical properties that can be produced in large quantities. Our product technologies focus on mycelium, the main component of fungi. This emerging biotechnology is used in the creation of carbon neutral products for the building, textile, packaging, and health care industries, as well as in the creation of supplements based on the proven health benefits of mushrooms.
Currently, our research focuses primarily on the significant thermal stability of mycelium materials, a result of mycelium's unique degradation qualities that expand the potential fields of application for mushroom-based products. Mushrooms, Inc.'s long-term goal is to build a strong scalable and widely recognized brand that authentically focuses on sustainable mushroom ingredients and novel functionality stemming from innovative biotech and materials science.
For more information, email info@mushroomsinc.com or visit www.mushroomsinc.com
07/19/2023 Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast Press Release
02/23/2023 Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release
04/20/2023 Quarterly Report for the period ended March 31, 2023
03/06/2023 Attorney Letter with Respect to Current Information - Shell Status Opinion MSRM
03/06/2023 Attorney Letter with Respect to Current Information - MSRM - Current Information Letter
03/06/2023 Annual Report - MSRM 2022 Annual Report
11/29/2022 Mushrooms, Inc. Announces Name and Ticker Symbol Change on OTC Markets to “MSRM” Press Release
https://www.otcmarkets.com/stock/MSRM/disclosure
08/23/2022 Marijuana Strategic Ventures, Inc. (OTC: MSVI) Now Mushrooms Inc., Announces Filing of Provisional Patent for Novel Mycelium Thread Press Release
Outstanding Shares 38,485,760 07/18/2023
Restricted 32,527,735 07/18/2023
Unrestricted 5,958,025 07/18/2023
Authorized Shares 400,000,000 07/18/2023
update by CEO:
see twitter https://twitter.com/MushroomsInc
MSRM This is totally under the Radar and is REAL. Check the SS , they did file a Patent that is coming up , they do have the product and their Mgt Team actually knows what they are doing.
https://otcmarkets.com/stock/MSRM/security
https://mushroomsinc.com/team-3
https://twitter.com/MushroomsInc
MSRM bottom entry/low floater: Update & Acquisitions...Unrestricted shares preserved at 6M
Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast.
Estero, FL, July 19, 2023 – Mushrooms Inc. (OTC: MSRM) (the “Company” or “MSRM) is pleased to announce that its CEO, Kimberly Carlson, recently appeared on the esteemed Psychedelic Spotlight Podcast to discuss the exciting potential of the industrial mushroom industry. As the first company trading on the US stock market focused on the industrial side of mushrooms, Mushrooms Inc. is leading the way in revolutionizing this emerging sector.
To watch or listen to the complete interview featuring Kimberly Carlson on Psychedelic Spotlight, please visit the following link: https://psychedelicspotlight.com/using-mycelium-for-a-sustainable-future-feat-kimberly-carlson/
During the podcast episode hosted by David Flores (CEO of Psychedelic Spotlight), Kimberly Carlson shared insights into the vision and mission of Mushrooms Inc. The Company is dedicated to supporting the growth of the mushroom industry through collaboration, innovation, and development. At the heart of Mushrooms Inc. lies a commitment to creating and supporting environmentally beneficial product innovation.
With a specific focus on the industrial application of mycelium, Mushrooms Inc. aims to develop carbon-neutral products for the building, textile, and healthcare industries. By harnessing the power of mycology, Mushrooms Inc. seeks to advance the creation of scientifically proven products that promote the health of the body, mind, and environment which includes remediation of toxic substances using mycelium also known as Myco-remediation.
Along with providing Mr. Flores with an overview of Mushrooms Inc., Ms. Carlson also shared insight into her own personal passion for working within the mushroom sector and why she believes mycelium holds the potential to promote a healthier and more sustainable environment for all of society.
"The potential of the industrial mushroom sector is immense, and Mushrooms Inc. is at the forefront of driving innovation in this field," said Kimberly Carlson, CEO of Mushrooms Inc. "Through our research and development efforts, we are committed to delivering sustainable solutions that benefit not only our customers but also the planet.
I am grateful for the opportunity to have had Mushrooms Inc. featured on the Psychedelic Spotlight Podcast, and more specifically, for the opportunity to provide their audience, as well as many others following the public markets, with an initial introduction into some the exiting things we have planned for MSRM.
In the weeks and months ahead, I look forward to being able to share some of the progress we anticipate making as we strive to truly position MSRM as an industrial mushroom leader.”
Mushrooms Inc. recognizes that true innovation comes from collaboration and learning from pioneers in the field. By fostering working relationships and engaging with experts in mycology, the Company is paving the way for groundbreaking advancements in the industry.
Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release | 02/23/2023
ESTERO, FL / ACCESSWIRE / February 23, 2023 / Mushrooms, Inc. (OTC PINK:MSRM) (the "Company") has been quietly making progress within this exciting multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology.
Mushrooms Inc. is developing profitable pathways to sustain the research and development branch which is necessary to achieve viable industrial innovation in this new field.
MSRM is targeting grants specific to their goals, working with pioneers, scientists, and universities, on a global scale to develop scientifically proven products that advance health of body, mind, and environment. They have multiple proposals that they are currently reviewing for their costs to bring to market, timelines, scalability, as well as their positive financial, environmental and health impact. These proposals include a patentable process for the development of mycelium-based building supplies, a patentable process for mushroom related cosmetic and anti-aging skin products, a superfood product not currently seen in the marketplace as well as several remediation projects with new product innovation as an end result. These proposals are being assessed while keeping the progress on an off-shore lab and scientists for an evolved patentable mycelium thread.
GROWTH STRATEGY
In order to offset research costs and time on the industrial development side we are establishing pillars of development outside of the industrial mushroom market through acquisitions and joint ventures. The business model is based on the amazing qualities of mycelium and its networking capabilities as well as its ability to benefit from the network its developing.
CEO Kimberly Carlson shared, "I have been fortunate to connect with amazing pioneers and innovators in differing areas of the Mushroom Market in the US and abroad. Three realities have been consistent with the people behind the businesses and their processes. One is that this business model can bring like-minded companies together in order to benefit and fruit from a shared network under the public umbrella. Secondly, there are natural and substantial cross-points between these companies to mutually benefit from each other while growing as a whole. And the third is that there is a desire for many of these businesses to unite their expertise to others and share from a unified gain. By combining the power of shared ideals and resources through joint ventures, we can move as larger more developed companies do, but without limiting quality and compassion for social and environmental governance."
With a focus on profitability and mutually beneficial cross points, MSRM is assessing partnerships with complimentary businesses which would strategically advance the Company's reach into related markets through joint ventures and M&A activity.
Establishing pillars of development outside of the industrial mushroom market allows for a broad scope of proven profitability and cross-sharing of resources.
We seek to enter partnerships in the Cultivation Market, which includes substrate, spawn production, and fruiting. Cultivation gives life to all market pillars to some degree. It feeds directly into the Mushroom Nutraceutical and Medicinal Psylocibin Market with the addition of extraction, quality testing, product development, and processing. The Medicinal Mushroom Market requires legalization and branches into wellness retreats, treatment certifications and clinics.
MSRM is also evaluating several companies involved in the Myco-Remediation Market which uses fungi to clean oil spills, heavy metals, plastics and other pollutants from soil, water, and the atmosphere. All of these markets relate to the industrial and health innovation that the Company is pursuing in differing aspects and creates a connecting point for acceleration, mutual benefit and market share.
It is the belief of MSRM that connecting these pillars of the mushroom market through joint ventures and acquisitions, while focusing their innovation efforts on the industrial side of the market, will garner cross benefits financially and accelerate timelines during the major research and development phases.
We are simultaneously creating a vertically integrated business model for the businesses involved by aligning strengths between the companies under the umbrella of MSRM.
From an investor perspective, we are creating an avenue for investors to support a larger portion of the mushroom market, establishing a broader financial base of support for and from the networked companies while allowing for a more elastic ability to pivot, expand and connect to new industry pathways as they surface.
Market Opportunity
Mushrooms, Inc. operates in the North American segment of the functional mushroom market in the mycelium material and mushroom supplement product types. According to various industrial research firms, the global functional mushroom market is projected to show a compounded annual growth rate of over 9% for the next five years (Industry Arc and Vantage Market Research). The North American edible mushroom market was worth 11.99 billion in 2023 and is growing at a compounded annual growth rate of 9.48%, forecast to reach 20.91 billion by 2028 (Market Data Forecast). The North American functional mushroom market held 33.8% of the global market in 2020 and is growing at a compounded annual growth rate of 7% (Industry Arc).
Overview
Mushrooms, Inc. is a developing-stage emerging consumer products platform focused on the manufacturing and marketing of highly differentiated mushroom-based materials and functional supplements. The core growth pillars of the Mushrooms, Inc. platform are currently based on developing functional mushroom technologies. As a result of growing consumer demand for innovative, sustainable, and carbon-neutral products, Mushrooms, Inc. plans to grow revenues by penetrating the multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology, as well as expanding our platform to include the creation of supplements based on the proven health benefits of mushrooms.
Mushrooms, Inc. seeks to drive the growth of the bourgeoning functional mushroom industry through product innovation and development. Our current core business activity is environmentally beneficial product innovation utilizing self-growing, fibrous, and natural composite materials with controlled physical properties that can be produced in large quantities. Our product technologies focus on mycelium, the main component of fungi. This emerging biotechnology is used in the creation of carbon neutral products for the building, textile, packaging, and health care industries, as well as in the creation of supplements based on the proven health benefits of mushrooms.
Currently, our research focuses primarily on the significant thermal stability of mycelium materials, a result of mycelium's unique degradation qualities that expand the potential fields of application for mushroom-based products. Mushrooms, Inc.'s long-term goal is to build a strong scalable and widely recognized brand that authentically focuses on sustainable mushroom ingredients and novel functionality stemming from innovative biotech and materials science.
For more information, email info@mushroomsinc.com or visit www.mushroomsinc.com
07/19/2023 Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast Press Release
02/23/2023 Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release
04/20/2023 Quarterly Report for the period ended March 31, 2023
03/06/2023 Attorney Letter with Respect to Current Information - Shell Status Opinion MSRM
03/06/2023 Attorney Letter with Respect to Current Information - MSRM - Current Information Letter
03/06/2023 Annual Report - MSRM 2022 Annual Report
11/29/2022 Mushrooms, Inc. Announces Name and Ticker Symbol Change on OTC Markets to “MSRM” Press Release
https://www.otcmarkets.com/stock/MSRM/disclosure
08/23/2022 Marijuana Strategic Ventures, Inc. (OTC: MSVI) Now Mushrooms Inc., Announces Filing of Provisional Patent for Novel Mycelium Thread Press Release
Outstanding Shares 38,485,760 07/18/2023
Restricted 32,527,735 07/18/2023
Unrestricted 5,958,025 07/18/2023
Authorized Shares 400,000,000 07/18/2023
update by CEO:
see twitter https://twitter.com/MushroomsInc
MSRM This is totally under the Radar and is REAL. Check the SS , they did file a Patent that is coming up , they do have the product and their Mgt Team actually knows what they are doing.
https://otcmarkets.com/stock/MSRM/security
https://mushroomsinc.com/team-3
https://twitter.com/MushroomsInc
MSRM: Update & Acquisitions...Unrestricted shares preserved at 6M
Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast.
Estero, FL, July 19, 2023 – Mushrooms Inc. (OTC: MSRM) (the “Company” or “MSRM) is pleased to announce that its CEO, Kimberly Carlson, recently appeared on the esteemed Psychedelic Spotlight Podcast to discuss the exciting potential of the industrial mushroom industry. As the first company trading on the US stock market focused on the industrial side of mushrooms, Mushrooms Inc. is leading the way in revolutionizing this emerging sector.
To watch or listen to the complete interview featuring Kimberly Carlson on Psychedelic Spotlight, please visit the following link: https://psychedelicspotlight.com/using-mycelium-for-a-sustainable-future-feat-kimberly-carlson/
During the podcast episode hosted by David Flores (CEO of Psychedelic Spotlight), Kimberly Carlson shared insights into the vision and mission of Mushrooms Inc. The Company is dedicated to supporting the growth of the mushroom industry through collaboration, innovation, and development. At the heart of Mushrooms Inc. lies a commitment to creating and supporting environmentally beneficial product innovation.
With a specific focus on the industrial application of mycelium, Mushrooms Inc. aims to develop carbon-neutral products for the building, textile, and healthcare industries. By harnessing the power of mycology, Mushrooms Inc. seeks to advance the creation of scientifically proven products that promote the health of the body, mind, and environment which includes remediation of toxic substances using mycelium also known as Myco-remediation.
Along with providing Mr. Flores with an overview of Mushrooms Inc., Ms. Carlson also shared insight into her own personal passion for working within the mushroom sector and why she believes mycelium holds the potential to promote a healthier and more sustainable environment for all of society.
"The potential of the industrial mushroom sector is immense, and Mushrooms Inc. is at the forefront of driving innovation in this field," said Kimberly Carlson, CEO of Mushrooms Inc. "Through our research and development efforts, we are committed to delivering sustainable solutions that benefit not only our customers but also the planet.
I am grateful for the opportunity to have had Mushrooms Inc. featured on the Psychedelic Spotlight Podcast, and more specifically, for the opportunity to provide their audience, as well as many others following the public markets, with an initial introduction into some the exiting things we have planned for MSRM.
In the weeks and months ahead, I look forward to being able to share some of the progress we anticipate making as we strive to truly position MSRM as an industrial mushroom leader.”
Mushrooms Inc. recognizes that true innovation comes from collaboration and learning from pioneers in the field. By fostering working relationships and engaging with experts in mycology, the Company is paving the way for groundbreaking advancements in the industry.
Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release | 02/23/2023
ESTERO, FL / ACCESSWIRE / February 23, 2023 / Mushrooms, Inc. (OTC PINK:MSRM) (the "Company") has been quietly making progress within this exciting multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology.
Mushrooms Inc. is developing profitable pathways to sustain the research and development branch which is necessary to achieve viable industrial innovation in this new field.
MSRM is targeting grants specific to their goals, working with pioneers, scientists, and universities, on a global scale to develop scientifically proven products that advance health of body, mind, and environment. They have multiple proposals that they are currently reviewing for their costs to bring to market, timelines, scalability, as well as their positive financial, environmental and health impact. These proposals include a patentable process for the development of mycelium-based building supplies, a patentable process for mushroom related cosmetic and anti-aging skin products, a superfood product not currently seen in the marketplace as well as several remediation projects with new product innovation as an end result. These proposals are being assessed while keeping the progress on an off-shore lab and scientists for an evolved patentable mycelium thread.
GROWTH STRATEGY
In order to offset research costs and time on the industrial development side we are establishing pillars of development outside of the industrial mushroom market through acquisitions and joint ventures. The business model is based on the amazing qualities of mycelium and its networking capabilities as well as its ability to benefit from the network its developing.
CEO Kimberly Carlson shared, "I have been fortunate to connect with amazing pioneers and innovators in differing areas of the Mushroom Market in the US and abroad. Three realities have been consistent with the people behind the businesses and their processes. One is that this business model can bring like-minded companies together in order to benefit and fruit from a shared network under the public umbrella. Secondly, there are natural and substantial cross-points between these companies to mutually benefit from each other while growing as a whole. And the third is that there is a desire for many of these businesses to unite their expertise to others and share from a unified gain. By combining the power of shared ideals and resources through joint ventures, we can move as larger more developed companies do, but without limiting quality and compassion for social and environmental governance."
With a focus on profitability and mutually beneficial cross points, MSRM is assessing partnerships with complimentary businesses which would strategically advance the Company's reach into related markets through joint ventures and M&A activity.
Establishing pillars of development outside of the industrial mushroom market allows for a broad scope of proven profitability and cross-sharing of resources.
We seek to enter partnerships in the Cultivation Market, which includes substrate, spawn production, and fruiting. Cultivation gives life to all market pillars to some degree. It feeds directly into the Mushroom Nutraceutical and Medicinal Psylocibin Market with the addition of extraction, quality testing, product development, and processing. The Medicinal Mushroom Market requires legalization and branches into wellness retreats, treatment certifications and clinics.
MSRM is also evaluating several companies involved in the Myco-Remediation Market which uses fungi to clean oil spills, heavy metals, plastics and other pollutants from soil, water, and the atmosphere. All of these markets relate to the industrial and health innovation that the Company is pursuing in differing aspects and creates a connecting point for acceleration, mutual benefit and market share.
It is the belief of MSRM that connecting these pillars of the mushroom market through joint ventures and acquisitions, while focusing their innovation efforts on the industrial side of the market, will garner cross benefits financially and accelerate timelines during the major research and development phases.
We are simultaneously creating a vertically integrated business model for the businesses involved by aligning strengths between the companies under the umbrella of MSRM.
From an investor perspective, we are creating an avenue for investors to support a larger portion of the mushroom market, establishing a broader financial base of support for and from the networked companies while allowing for a more elastic ability to pivot, expand and connect to new industry pathways as they surface.
Market Opportunity
Mushrooms, Inc. operates in the North American segment of the functional mushroom market in the mycelium material and mushroom supplement product types. According to various industrial research firms, the global functional mushroom market is projected to show a compounded annual growth rate of over 9% for the next five years (Industry Arc and Vantage Market Research). The North American edible mushroom market was worth 11.99 billion in 2023 and is growing at a compounded annual growth rate of 9.48%, forecast to reach 20.91 billion by 2028 (Market Data Forecast). The North American functional mushroom market held 33.8% of the global market in 2020 and is growing at a compounded annual growth rate of 7% (Industry Arc).
Overview
Mushrooms, Inc. is a developing-stage emerging consumer products platform focused on the manufacturing and marketing of highly differentiated mushroom-based materials and functional supplements. The core growth pillars of the Mushrooms, Inc. platform are currently based on developing functional mushroom technologies. As a result of growing consumer demand for innovative, sustainable, and carbon-neutral products, Mushrooms, Inc. plans to grow revenues by penetrating the multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology, as well as expanding our platform to include the creation of supplements based on the proven health benefits of mushrooms.
Mushrooms, Inc. seeks to drive the growth of the bourgeoning functional mushroom industry through product innovation and development. Our current core business activity is environmentally beneficial product innovation utilizing self-growing, fibrous, and natural composite materials with controlled physical properties that can be produced in large quantities. Our product technologies focus on mycelium, the main component of fungi. This emerging biotechnology is used in the creation of carbon neutral products for the building, textile, packaging, and health care industries, as well as in the creation of supplements based on the proven health benefits of mushrooms.
Currently, our research focuses primarily on the significant thermal stability of mycelium materials, a result of mycelium's unique degradation qualities that expand the potential fields of application for mushroom-based products. Mushrooms, Inc.'s long-term goal is to build a strong scalable and widely recognized brand that authentically focuses on sustainable mushroom ingredients and novel functionality stemming from innovative biotech and materials science.
For more information, email info@mushroomsinc.com or visit www.mushroomsinc.com
07/19/2023 Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast Press Release
02/23/2023 Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release
04/20/2023 Quarterly Report for the period ended March 31, 2023
03/06/2023 Attorney Letter with Respect to Current Information - Shell Status Opinion MSRM
03/06/2023 Attorney Letter with Respect to Current Information - MSRM - Current Information Letter
03/06/2023 Annual Report - MSRM 2022 Annual Report
11/29/2022 Mushrooms, Inc. Announces Name and Ticker Symbol Change on OTC Markets to “MSRM” Press Release
https://www.otcmarkets.com/stock/MSRM/disclosure
08/23/2022 Marijuana Strategic Ventures, Inc. (OTC: MSVI) Now Mushrooms Inc., Announces Filing of Provisional Patent for Novel Mycelium Thread Press Release
Outstanding Shares 38,485,760 07/18/2023
Restricted 32,527,735 07/18/2023
Unrestricted 5,958,025 07/18/2023
Authorized Shares 400,000,000 07/18/2023
update by CEO:
see twitter https://twitter.com/MushroomsInc
MSRM This is totally under the Radar and is REAL. Check the SS , they did file a Patent that is coming up , they do have the product and their Mgt Team actually knows what they are doing.
https://otcmarkets.com/stock/MSRM/security
https://mushroomsinc.com/team-3
https://twitter.com/MushroomsInc
MSRM: Update & Acquisitions...Unrestricted shares preserved at 5.9M
Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast.
Estero, FL, July 19, 2023 – Mushrooms Inc. (OTC: MSRM) (the “Company” or “MSRM) is pleased to announce that its CEO, Kimberly Carlson, recently appeared on the esteemed Psychedelic Spotlight Podcast to discuss the exciting potential of the industrial mushroom industry. As the first company trading on the US stock market focused on the industrial side of mushrooms, Mushrooms Inc. is leading the way in revolutionizing this emerging sector.
To watch or listen to the complete interview featuring Kimberly Carlson on Psychedelic Spotlight, please visit the following link: https://psychedelicspotlight.com/using-mycelium-for-a-sustainable-future-feat-kimberly-carlson/
During the podcast episode hosted by David Flores (CEO of Psychedelic Spotlight), Kimberly Carlson shared insights into the vision and mission of Mushrooms Inc. The Company is dedicated to supporting the growth of the mushroom industry through collaboration, innovation, and development. At the heart of Mushrooms Inc. lies a commitment to creating and supporting environmentally beneficial product innovation.
With a specific focus on the industrial application of mycelium, Mushrooms Inc. aims to develop carbon-neutral products for the building, textile, and healthcare industries. By harnessing the power of mycology, Mushrooms Inc. seeks to advance the creation of scientifically proven products that promote the health of the body, mind, and environment which includes remediation of toxic substances using mycelium also known as Myco-remediation.
Along with providing Mr. Flores with an overview of Mushrooms Inc., Ms. Carlson also shared insight into her own personal passion for working within the mushroom sector and why she believes mycelium holds the potential to promote a healthier and more sustainable environment for all of society.
"The potential of the industrial mushroom sector is immense, and Mushrooms Inc. is at the forefront of driving innovation in this field," said Kimberly Carlson, CEO of Mushrooms Inc. "Through our research and development efforts, we are committed to delivering sustainable solutions that benefit not only our customers but also the planet.
I am grateful for the opportunity to have had Mushrooms Inc. featured on the Psychedelic Spotlight Podcast, and more specifically, for the opportunity to provide their audience, as well as many others following the public markets, with an initial introduction into some the exiting things we have planned for MSRM.
In the weeks and months ahead, I look forward to being able to share some of the progress we anticipate making as we strive to truly position MSRM as an industrial mushroom leader.”
Mushrooms Inc. recognizes that true innovation comes from collaboration and learning from pioneers in the field. By fostering working relationships and engaging with experts in mycology, the Company is paving the way for groundbreaking advancements in the industry.
Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release | 02/23/2023
ESTERO, FL / ACCESSWIRE / February 23, 2023 / Mushrooms, Inc. (OTC PINK:MSRM) (the "Company") has been quietly making progress within this exciting multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology.
Mushrooms Inc. is developing profitable pathways to sustain the research and development branch which is necessary to achieve viable industrial innovation in this new field.
MSRM is targeting grants specific to their goals, working with pioneers, scientists, and universities, on a global scale to develop scientifically proven products that advance health of body, mind, and environment. They have multiple proposals that they are currently reviewing for their costs to bring to market, timelines, scalability, as well as their positive financial, environmental and health impact. These proposals include a patentable process for the development of mycelium-based building supplies, a patentable process for mushroom related cosmetic and anti-aging skin products, a superfood product not currently seen in the marketplace as well as several remediation projects with new product innovation as an end result. These proposals are being assessed while keeping the progress on an off-shore lab and scientists for an evolved patentable mycelium thread.
GROWTH STRATEGY
In order to offset research costs and time on the industrial development side we are establishing pillars of development outside of the industrial mushroom market through acquisitions and joint ventures. The business model is based on the amazing qualities of mycelium and its networking capabilities as well as its ability to benefit from the network its developing.
CEO Kimberly Carlson shared, "I have been fortunate to connect with amazing pioneers and innovators in differing areas of the Mushroom Market in the US and abroad. Three realities have been consistent with the people behind the businesses and their processes. One is that this business model can bring like-minded companies together in order to benefit and fruit from a shared network under the public umbrella. Secondly, there are natural and substantial cross-points between these companies to mutually benefit from each other while growing as a whole. And the third is that there is a desire for many of these businesses to unite their expertise to others and share from a unified gain. By combining the power of shared ideals and resources through joint ventures, we can move as larger more developed companies do, but without limiting quality and compassion for social and environmental governance."
With a focus on profitability and mutually beneficial cross points, MSRM is assessing partnerships with complimentary businesses which would strategically advance the Company's reach into related markets through joint ventures and M&A activity.
Establishing pillars of development outside of the industrial mushroom market allows for a broad scope of proven profitability and cross-sharing of resources.
We seek to enter partnerships in the Cultivation Market, which includes substrate, spawn production, and fruiting. Cultivation gives life to all market pillars to some degree. It feeds directly into the Mushroom Nutraceutical and Medicinal Psylocibin Market with the addition of extraction, quality testing, product development, and processing. The Medicinal Mushroom Market requires legalization and branches into wellness retreats, treatment certifications and clinics.
MSRM is also evaluating several companies involved in the Myco-Remediation Market which uses fungi to clean oil spills, heavy metals, plastics and other pollutants from soil, water, and the atmosphere. All of these markets relate to the industrial and health innovation that the Company is pursuing in differing aspects and creates a connecting point for acceleration, mutual benefit and market share.
It is the belief of MSRM that connecting these pillars of the mushroom market through joint ventures and acquisitions, while focusing their innovation efforts on the industrial side of the market, will garner cross benefits financially and accelerate timelines during the major research and development phases.
We are simultaneously creating a vertically integrated business model for the businesses involved by aligning strengths between the companies under the umbrella of MSRM.
From an investor perspective, we are creating an avenue for investors to support a larger portion of the mushroom market, establishing a broader financial base of support for and from the networked companies while allowing for a more elastic ability to pivot, expand and connect to new industry pathways as they surface.
Market Opportunity
Mushrooms, Inc. operates in the North American segment of the functional mushroom market in the mycelium material and mushroom supplement product types. According to various industrial research firms, the global functional mushroom market is projected to show a compounded annual growth rate of over 9% for the next five years (Industry Arc and Vantage Market Research). The North American edible mushroom market was worth 11.99 billion in 2023 and is growing at a compounded annual growth rate of 9.48%, forecast to reach 20.91 billion by 2028 (Market Data Forecast). The North American functional mushroom market held 33.8% of the global market in 2020 and is growing at a compounded annual growth rate of 7% (Industry Arc).
Overview
Mushrooms, Inc. is a developing-stage emerging consumer products platform focused on the manufacturing and marketing of highly differentiated mushroom-based materials and functional supplements. The core growth pillars of the Mushrooms, Inc. platform are currently based on developing functional mushroom technologies. As a result of growing consumer demand for innovative, sustainable, and carbon-neutral products, Mushrooms, Inc. plans to grow revenues by penetrating the multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology, as well as expanding our platform to include the creation of supplements based on the proven health benefits of mushrooms.
Mushrooms, Inc. seeks to drive the growth of the bourgeoning functional mushroom industry through product innovation and development. Our current core business activity is environmentally beneficial product innovation utilizing self-growing, fibrous, and natural composite materials with controlled physical properties that can be produced in large quantities. Our product technologies focus on mycelium, the main component of fungi. This emerging biotechnology is used in the creation of carbon neutral products for the building, textile, packaging, and health care industries, as well as in the creation of supplements based on the proven health benefits of mushrooms.
Currently, our research focuses primarily on the significant thermal stability of mycelium materials, a result of mycelium's unique degradation qualities that expand the potential fields of application for mushroom-based products. Mushrooms, Inc.'s long-term goal is to build a strong scalable and widely recognized brand that authentically focuses on sustainable mushroom ingredients and novel functionality stemming from innovative biotech and materials science.
For more information, email info@mushroomsinc.com or visit www.mushroomsinc.com
07/19/2023 Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast Press Release
02/23/2023 Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release
04/20/2023 Quarterly Report for the period ended March 31, 2023
03/06/2023 Attorney Letter with Respect to Current Information - Shell Status Opinion MSRM
03/06/2023 Attorney Letter with Respect to Current Information - MSRM - Current Information Letter
03/06/2023 Annual Report - MSRM 2022 Annual Report
11/29/2022 Mushrooms, Inc. Announces Name and Ticker Symbol Change on OTC Markets to “MSRM” Press Release
https://www.otcmarkets.com/stock/MSRM/disclosure
08/23/2022 Marijuana Strategic Ventures, Inc. (OTC: MSVI) Now Mushrooms Inc., Announces Filing of Provisional Patent for Novel Mycelium Thread Press Release
Outstanding Shares 38,485,760 07/18/2023
Restricted 32,527,735 07/18/2023
Unrestricted 5,958,025 07/18/2023
Authorized Shares 400,000,000 07/18/2023
update by CEO:
see twitter https://twitter.com/MushroomsInc
MSRM This is totally under the Radar and is REAL. Check the SS , they did file a Patent that is coming up , they do have the product and their Mgt Team actually knows what they are doing.
https://otcmarkets.com/stock/MSRM/security
https://mushroomsinc.com/team-3
https://twitter.com/MushroomsInc
MSRM: Update & Acquisitions...Unrestricted shares preserved at 6M
Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast.
Estero, FL, July 19, 2023 – Mushrooms Inc. (OTC: MSRM) (the “Company” or “MSRM) is pleased to announce that its CEO, Kimberly Carlson, recently appeared on the esteemed Psychedelic Spotlight Podcast to discuss the exciting potential of the industrial mushroom industry. As the first company trading on the US stock market focused on the industrial side of mushrooms, Mushrooms Inc. is leading the way in revolutionizing this emerging sector.
To watch or listen to the complete interview featuring Kimberly Carlson on Psychedelic Spotlight, please visit the following link: https://psychedelicspotlight.com/using-mycelium-for-a-sustainable-future-feat-kimberly-carlson/
During the podcast episode hosted by David Flores (CEO of Psychedelic Spotlight), Kimberly Carlson shared insights into the vision and mission of Mushrooms Inc. The Company is dedicated to supporting the growth of the mushroom industry through collaboration, innovation, and development. At the heart of Mushrooms Inc. lies a commitment to creating and supporting environmentally beneficial product innovation.
With a specific focus on the industrial application of mycelium, Mushrooms Inc. aims to develop carbon-neutral products for the building, textile, and healthcare industries. By harnessing the power of mycology, Mushrooms Inc. seeks to advance the creation of scientifically proven products that promote the health of the body, mind, and environment which includes remediation of toxic substances using mycelium also known as Myco-remediation.
Along with providing Mr. Flores with an overview of Mushrooms Inc., Ms. Carlson also shared insight into her own personal passion for working within the mushroom sector and why she believes mycelium holds the potential to promote a healthier and more sustainable environment for all of society.
"The potential of the industrial mushroom sector is immense, and Mushrooms Inc. is at the forefront of driving innovation in this field," said Kimberly Carlson, CEO of Mushrooms Inc. "Through our research and development efforts, we are committed to delivering sustainable solutions that benefit not only our customers but also the planet.
I am grateful for the opportunity to have had Mushrooms Inc. featured on the Psychedelic Spotlight Podcast, and more specifically, for the opportunity to provide their audience, as well as many others following the public markets, with an initial introduction into some the exiting things we have planned for MSRM.
In the weeks and months ahead, I look forward to being able to share some of the progress we anticipate making as we strive to truly position MSRM as an industrial mushroom leader.”
Mushrooms Inc. recognizes that true innovation comes from collaboration and learning from pioneers in the field. By fostering working relationships and engaging with experts in mycology, the Company is paving the way for groundbreaking advancements in the industry.
Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release | 02/23/2023
ESTERO, FL / ACCESSWIRE / February 23, 2023 / Mushrooms, Inc. (OTC PINK:MSRM) (the "Company") has been quietly making progress within this exciting multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology.
Mushrooms Inc. is developing profitable pathways to sustain the research and development branch which is necessary to achieve viable industrial innovation in this new field.
MSRM is targeting grants specific to their goals, working with pioneers, scientists, and universities, on a global scale to develop scientifically proven products that advance health of body, mind, and environment. They have multiple proposals that they are currently reviewing for their costs to bring to market, timelines, scalability, as well as their positive financial, environmental and health impact. These proposals include a patentable process for the development of mycelium-based building supplies, a patentable process for mushroom related cosmetic and anti-aging skin products, a superfood product not currently seen in the marketplace as well as several remediation projects with new product innovation as an end result. These proposals are being assessed while keeping the progress on an off-shore lab and scientists for an evolved patentable mycelium thread.
GROWTH STRATEGY
In order to offset research costs and time on the industrial development side we are establishing pillars of development outside of the industrial mushroom market through acquisitions and joint ventures. The business model is based on the amazing qualities of mycelium and its networking capabilities as well as its ability to benefit from the network its developing.
CEO Kimberly Carlson shared, "I have been fortunate to connect with amazing pioneers and innovators in differing areas of the Mushroom Market in the US and abroad. Three realities have been consistent with the people behind the businesses and their processes. One is that this business model can bring like-minded companies together in order to benefit and fruit from a shared network under the public umbrella. Secondly, there are natural and substantial cross-points between these companies to mutually benefit from each other while growing as a whole. And the third is that there is a desire for many of these businesses to unite their expertise to others and share from a unified gain. By combining the power of shared ideals and resources through joint ventures, we can move as larger more developed companies do, but without limiting quality and compassion for social and environmental governance."
With a focus on profitability and mutually beneficial cross points, MSRM is assessing partnerships with complimentary businesses which would strategically advance the Company's reach into related markets through joint ventures and M&A activity.
Establishing pillars of development outside of the industrial mushroom market allows for a broad scope of proven profitability and cross-sharing of resources.
We seek to enter partnerships in the Cultivation Market, which includes substrate, spawn production, and fruiting. Cultivation gives life to all market pillars to some degree. It feeds directly into the Mushroom Nutraceutical and Medicinal Psylocibin Market with the addition of extraction, quality testing, product development, and processing. The Medicinal Mushroom Market requires legalization and branches into wellness retreats, treatment certifications and clinics.
MSRM is also evaluating several companies involved in the Myco-Remediation Market which uses fungi to clean oil spills, heavy metals, plastics and other pollutants from soil, water, and the atmosphere. All of these markets relate to the industrial and health innovation that the Company is pursuing in differing aspects and creates a connecting point for acceleration, mutual benefit and market share.
It is the belief of MSRM that connecting these pillars of the mushroom market through joint ventures and acquisitions, while focusing their innovation efforts on the industrial side of the market, will garner cross benefits financially and accelerate timelines during the major research and development phases.
We are simultaneously creating a vertically integrated business model for the businesses involved by aligning strengths between the companies under the umbrella of MSRM.
From an investor perspective, we are creating an avenue for investors to support a larger portion of the mushroom market, establishing a broader financial base of support for and from the networked companies while allowing for a more elastic ability to pivot, expand and connect to new industry pathways as they surface.
Market Opportunity
Mushrooms, Inc. operates in the North American segment of the functional mushroom market in the mycelium material and mushroom supplement product types. According to various industrial research firms, the global functional mushroom market is projected to show a compounded annual growth rate of over 9% for the next five years (Industry Arc and Vantage Market Research). The North American edible mushroom market was worth 11.99 billion in 2023 and is growing at a compounded annual growth rate of 9.48%, forecast to reach 20.91 billion by 2028 (Market Data Forecast). The North American functional mushroom market held 33.8% of the global market in 2020 and is growing at a compounded annual growth rate of 7% (Industry Arc).
Overview
Mushrooms, Inc. is a developing-stage emerging consumer products platform focused on the manufacturing and marketing of highly differentiated mushroom-based materials and functional supplements. The core growth pillars of the Mushrooms, Inc. platform are currently based on developing functional mushroom technologies. As a result of growing consumer demand for innovative, sustainable, and carbon-neutral products, Mushrooms, Inc. plans to grow revenues by penetrating the multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology, as well as expanding our platform to include the creation of supplements based on the proven health benefits of mushrooms.
Mushrooms, Inc. seeks to drive the growth of the bourgeoning functional mushroom industry through product innovation and development. Our current core business activity is environmentally beneficial product innovation utilizing self-growing, fibrous, and natural composite materials with controlled physical properties that can be produced in large quantities. Our product technologies focus on mycelium, the main component of fungi. This emerging biotechnology is used in the creation of carbon neutral products for the building, textile, packaging, and health care industries, as well as in the creation of supplements based on the proven health benefits of mushrooms.
Currently, our research focuses primarily on the significant thermal stability of mycelium materials, a result of mycelium's unique degradation qualities that expand the potential fields of application for mushroom-based products. Mushrooms, Inc.'s long-term goal is to build a strong scalable and widely recognized brand that authentically focuses on sustainable mushroom ingredients and novel functionality stemming from innovative biotech and materials science.
For more information, email info@mushroomsinc.com or visit www.mushroomsinc.com
07/19/2023 Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast Press Release
02/23/2023 Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release
04/20/2023 Quarterly Report for the period ended March 31, 2023
03/06/2023 Attorney Letter with Respect to Current Information - Shell Status Opinion MSRM
03/06/2023 Attorney Letter with Respect to Current Information - MSRM - Current Information Letter
03/06/2023 Annual Report - MSRM 2022 Annual Report
11/29/2022 Mushrooms, Inc. Announces Name and Ticker Symbol Change on OTC Markets to “MSRM” Press Release
https://www.otcmarkets.com/stock/MSRM/disclosure
08/23/2022 Marijuana Strategic Ventures, Inc. (OTC: MSVI) Now Mushrooms Inc., Announces Filing of Provisional Patent for Novel Mycelium Thread Press Release
Outstanding Shares 38,485,760 07/18/2023
Restricted 32,527,735 07/18/2023
Unrestricted 5,958,025 07/18/2023
Authorized Shares 400,000,000 07/18/2023
update by CEO:
see twitter https://twitter.com/MushroomsInc
MSRM This is totally under the Radar and is REAL. Check the SS , they did file a Patent that is coming up , they do have the product and their Mgt Team actually knows what they are doing.
https://otcmarkets.com/stock/MSRM/security
https://mushroomsinc.com/team-3
https://twitter.com/MushroomsInc
Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast.
Estero, FL, July 19, 2023 – Mushrooms Inc. (OTC: MSRM) (the “Company” or “MSRM) is pleased to announce that its CEO, Kimberly Carlson, recently appeared on the esteemed Psychedelic Spotlight Podcast to discuss the exciting potential of the industrial mushroom industry. As the first company trading on the US stock market focused on the industrial side of mushrooms, Mushrooms Inc. is leading the way in revolutionizing this emerging sector.
To watch or listen to the complete interview featuring Kimberly Carlson on Psychedelic Spotlight, please visit the following link: https://psychedelicspotlight.com/using-mycelium-for-a-sustainable-future-feat-kimberly-carlson/
During the podcast episode hosted by David Flores (CEO of Psychedelic Spotlight), Kimberly Carlson shared insights into the vision and mission of Mushrooms Inc. The Company is dedicated to supporting the growth of the mushroom industry through collaboration, innovation, and development. At the heart of Mushrooms Inc. lies a commitment to creating and supporting environmentally beneficial product innovation.
With a specific focus on the industrial application of mycelium, Mushrooms Inc. aims to develop carbon-neutral products for the building, textile, and healthcare industries. By harnessing the power of mycology, Mushrooms Inc. seeks to advance the creation of scientifically proven products that promote the health of the body, mind, and environment which includes remediation of toxic substances using mycelium also known as Myco-remediation.
Along with providing Mr. Flores with an overview of Mushrooms Inc., Ms. Carlson also shared insight into her own personal passion for working within the mushroom sector and why she believes mycelium holds the potential to promote a healthier and more sustainable environment for all of society.
"The potential of the industrial mushroom sector is immense, and Mushrooms Inc. is at the forefront of driving innovation in this field," said Kimberly Carlson, CEO of Mushrooms Inc. "Through our research and development efforts, we are committed to delivering sustainable solutions that benefit not only our customers but also the planet.
I am grateful for the opportunity to have had Mushrooms Inc. featured on the Psychedelic Spotlight Podcast, and more specifically, for the opportunity to provide their audience, as well as many others following the public markets, with an initial introduction into some the exiting things we have planned for MSRM.
In the weeks and months ahead, I look forward to being able to share some of the progress we anticipate making as we strive to truly position MSRM as an industrial mushroom leader.”
Mushrooms Inc. recognizes that true innovation comes from collaboration and learning from pioneers in the field. By fostering working relationships and engaging with experts in mycology, the Company is paving the way for groundbreaking advancements in the industry.
For more information about Mushrooms Inc., please email info@mushroomsinc.com or visit www.mushroomsinc.com.
management miscalculated pps and the earlier announced small RS while trying to establish a business model...now they have no option other than to even do a larger RS as evident by the supposed 1/1000...sucks for current shareholders, even though on the long run, business (thus trading) might be unfolding nicely
Market Cap Market Cap 762,018 07/13/2023
Outstanding Shares 38,485,760 07/13/2023
Restricted 32,527,735 07/13/2023
Unrestricted 5,958,025 07/13/2023
in march that RS was cancelled BUT it was fairly well established by a poster here that a NV filing in June took place to conduct a RS 1000:1 and reduce the AS to 1B from now 4B (these numbers of AS say it all when the outstanding right now is just 185M)
The easiest would have been a screenshot by you posted here, since you paid and viewed it. But from the companies perspective it makes sense, and it sucks to be a a shareholder right now.
Market cap $670k (or if one just takes unrestricted shares into account $102k)...the CEO is right now working on contracts...a no brainer to buy and hold until the pps shoots up
No SS CHANGE IN 2 YEARS and revenue-increase quarterly to almost $1M annually and caught up with all necessary filings/financials (we all know that this usually is to set up for major events) and June 14th 2023 reinstated ( https://search.sunbiz.org/Inquiry/CorporationSearch/GetDocument?aggregateId=domp-p14000090730-1bf8e2d0-ceaa-47f9-b1db-473ac4e0b6a8&transactionId=p14000090730-re-e19a8b32-a187-4c68-a556-f98d7d2eee53&formatType=PDF) so literally coming back from the dead :). Also; $290M to collect | $18.7M assets | $1.6M MC
Outstanding Shares 5,304,836,058 06/15/2023
Restricted 326,685,443 06/15/2023
Unrestricted 4,978,150,615 06/15/2023
Outstanding Shares 5,304,836,058 11/08/2021
Restricted 326,685,443 11/08/2021
Unrestricted 4,978,150,615 11/08/2021
I'm collecting...12M for now
PPJE SS HAS NOT CHANGED IN TWO YEARS while the revenue increased quarterly to almost $1M annually and caught up with all necessary filings/financials (we all know that this usually is to set up for major events) and June 14th 2023 reinstated ( https://search.sunbiz.org/Inquiry/CorporationSearch/GetDocument?aggregateId=domp-p14000090730-1bf8e2d0-ceaa-47f9-b1db-473ac4e0b6a8&transactionId=p14000090730-re-e19a8b32-a187-4c68-a556-f98d7d2eee53&formatType=PDF) so literally coming back from the dead :)
Outstanding Shares 5,304,836,058 06/15/2023
Restricted 326,685,443 06/15/2023
Unrestricted 4,978,150,615 06/15/2023
Outstanding Shares 5,304,836,058 11/08/2021
Restricted 326,685,443 11/08/2021
Unrestricted 4,978,150,615 11/08/2021
reinstated!...gross profits ~300k per quarter!...will move up with patience....loading now is a no brainer IMO
out of the trips just on quarterly gross profits of ~300k and a market can now of only 1.8M as well as filings to current possible
if you want the pps to explode just post a screenshot of the settlement proof
Just recently cancelled a 20:1 RS....weird management
yes...needs a few of these decisive buys (100k+) off the ask, though, like yesterday to finally move up
no debt whatshowever and no shares added to OS ever...should spike anytime...collect and wait
Across the OTC stocks are in a coma for along while already. Some spike here and there but no runners. Once this phase is over and money pours in, MSTO like some others in the trips with small OS will run like crazy.
market cap right now $380.000....nice joke and setting up for a 10X+ run
Might very well be the last intra-MM flush resp washtrade (no OS shares added)...I added another 2m
BURFORD, GA / ACCESSWIRE / June 1, 2023 / MasterBeat Corporation (OTC:MSTO), a company specializing in hard, tangible asset acquisitions with an intense focus on real estate and other tangible assets, through its subsidiary SBQ Holdings, LLC, established for the purpose of acquiring, developing, and managing short term rental and vacation homes is pleased to provide the following update.
We are delighted to announce that we have regained our Pink Current status on the OTC Markets and are in the process of filing our Form 211 to get back to the solicited quote status. Malone Bailey is currently working on the 2021 financials, and we plan to get our 2022 audited as well. Furthermore, progress on the Navarre and Santa Rosa properties purchased in June and July of 2021 are moving along with an expected completion date for both projects to be in November 2023.
Masterbeat's objective has been to prove its successful business models in the Real Estate and Automotive industries. Our pilot real estate project, initiated in 2019/2020, was aimed at generating revenues, profitability, asset appreciation and self-sustainability. Even under the difficult circumstances created by the COVID pandemic, our pilot projects, such as the purchase of the Verano Palace property for $1.1 million and its subsequent short-term rental, have proven to be successful. We were able to rent the property and it was eventually sold for $1.4 million, demonstrating the success of one segment of our Real Estate business model. The second venture was the purchase of the Santa Rosa property Land Lot 183 Rolling Dunes, acquired in February 2021 with the intention to develop and build a 5000 sq ft short term vacation property for the purpose of resale being another segment of our Real Estate model. The land purchase cost was ($400,000) and building cost was estimated to be approximately ($1.2million), adding up to a total gross cost of ($1.6million), with our actual all-in cost being $1.85million, completed and furnished. The property was sold for $4.25 million. SBQ's real estate achievements have exceeded our business goals, confirming the efficacy of our Real Estate business model even in challenging times such as the COVID pandemic. Masterbeat's subsidiary, SBQ Holdings, will remain focused on land purchases and development. The company will concentrate on acquiring properties in the Florida Panhandle and other highly rated areas for vacation rentals based on cost of ownership, short-term revenue potential, acquisition cost, annual appreciation, and projected changes in asset value.
SBQ's will continue to develop Vacation Rental properties for resale purposes until market conditions are more favorable to keep the properties and rent them out. Our automotive division, JTEC Automotive Inc, did not perform as well during the pandemic and after due to supply chain issues that hindered our ability to deliver parts to customers in a timely manner. The Automotive Parts Industry has been severely affected by the fact that ninety percent (90%) of all aftermarket auto parts are produced outside the United States. Shipping issues and lack of raw materials to manufacture parts have made it very hard to acquire auto parts, resulting in back orders with no definitive delivery dates. Therefore, MasterBeat has decided to close its automotive division and focus on the real estate sector, which has provided us with the best returns on capital investment and time. In 2023 and 2024, we plan to aggressively implement our land acquisition strategy to build our portfolio of large vacation style short term rental properties. The increasing popularity of short-term rental platforms such as Airbnb, HomeAway, Flipkey and the Hilton Hotel & Resorts have created an immense demand for Short-term Vacation Rentals, and we anticipate double-digit growth over the next five years. ‘We are confident that, as we restructure our business model and focus solely on the Real Estate sector, we will be able to create better business relationships in the financial industry, allowing us to raise the necessary capital for our growth with an ambitious land acquisition plan.' Stated, Josh Tannariello
About MasterBeat Corp.
MasterBeat Corporation (OTC:MSTO), incorporated under the laws of Delaware, is a publicly traded company specializing in hard, tangible asset acquisitions with an intense focus on real estate, precious metals, and other tangible assets. The company believes its progressive approach to an old school model, especially in this market based on fragile earnings multiples and uncertainty, to acquire hard, tangible assets will not only offer long term capital appreciation but also deliver revenues, profits, and self-sustainability.
www.masterbeatcorp.com
info@masterbeatcorp.com
LTCP: New CEO! Interim CEO now chairman, Unrestricted shares preserved at tiny 22M, chart: bottom now with 29cent pps spike 1.5 years ago - looking for repeat
Life’s Time Capsule Announces Amedeo “ Dino “ Sgueglia as New CEO; Press Release | 05/31/2023
https://www.otcmarkets.com/stock/LTCP/disclosure
New York May 31, 2023 Lifes Time Capsule Services, Inc. (OTC: LTCP) today announced that effective immediately, Amedeo Dino Sgueglia has accepted the role of CEO, replacing Edward Gibstein, who has served as Interim CEO. Mr. Sgueglia will also join LTCPs Board of Directors. Mr. Gibstein will stay on with LTCP in his new role as Chairman of the Board.
First announced as a consultant in April, as CEO Mr. Sgueglia brings a history of success, credibility, and experience to LTCP. One of his successes led to the sale in 2017, of the company that he built from its inception. At the time of the sale, that company was the largest credit card processor for the Taxicab Industry in the US.
Dino is the first of multiple hires for LTCP as we build our Management and C-suite Executive teams, said Gibstein. I am extremely pleased to have a person with a history of success, who is focused on building brand recognition, revenue expansion, and shareholder value. His background and experience fit our agenda.
Mr. Sgueglia has an extensive background in the Hemp and Cannabis industries and has successfully grown several generations of CBG genetics, through a patented extraction technology. Mr. Sgueglia is a member of the Board of Directors of ProGro Bio, a microbial science company in the Agri-Tech industry.
He has a talent for developing brands, creating marketing strategies, and identifying key people, partners, and strategic alliances. He also has a proven background
in structuring acquisition strategies and raising money.
I am very excited about the opportunity to build shareholder value by growing our technology platform and identifying accretive businesses for acquisition, said Sgueglia.
yes, but is the process it reversible once the response by the company to the order is not satisfying or not timely
eight days to respond:
https://www.sec.gov/files/litigation/admin/2023/34-97569.pdf
thanks for digging into this
MSTO: tier now PINK (change from expert to Pink limited to current). No brainer to collect some NOW IMO.
05/15/2023 Quarterly Report - Q1 2023
04/18/2023 Attorney Letter with Respect to Current Information
04/17/2023 Annual Report - Annual Report
Outstanding Shares 1,265,434,915 05/24/2023
Restricted 32,345,325 05/24/2023
Unrestricted 1,233,089,590 05/24 2023
https://www.otcmarkets.com/otcapi/company/financial-report/365752/content
CEO via tweets: "updates coming" & " watch for announcements of progress being made at both Navarre and Baird Rd Properties"
website: https://www.masterbeatcorp.com/
Twitter: https://twitter.com/masterbeatcorp
Subsidiaries:
SBQ Holdings, LLC https://twitter.com/LlcSbq
JTEC Automotive, Inc. https://twitter.com/AutomotiveJtec
Masterbeat Corporation owns 70% of its subsidiary SBQ, LLC. The remaining 30% is owned by its current Chief Executive Officer.
Financing through offering at 0.001 (2x over current pps)
((https://www.otcmarkets.com/filing/conv_pdf?id=16474224&guid=tFm-ka3VoTiqJth
updates soon to stream in while market cap today a lousy 500K...ok, lets say 10x easy :)
no dilution (Outstanding Shares 37,985,760 05/18/2023) with most restricted
(32,782,535 05/18/2023)....and, indeed nice absorption of 500K today without pps decline!
the biggest news is that RXMD revenues are steadily climbing QoQ and YoY (from $10M) to $45M while the market cap at this pps is a ridiculous $20M. In this sector the P/E ratio would give RXMD a fair value market cap of ~$200M which would be a pps of ~$40
10fold undervalued!!!!